Promoters for regulation of gene expression in plant roots

专利摘要:

公开号:AU2007202802A1
申请号:U2007202802
申请日:2007-06-15
公开日:2007-07-12
发明作者:Kay Lawton；Stephen B. Milligan；Dale Skalla
申请人:Syngenta Participations AG；
IPC主号:A01H1-00

专利说明:
P/00/011 Regulation 3 2
AUSTRALIA
Patents Act 1990 COMPLETE SPECIFICATION 0 t-
(,N
STANDARD PATENT
(ORIGINAL)
Name of Applicant(s): Actual Inventor(s): Syngenta Participations AG, of Schwarzwaldallee 215, CH-4058 Basel, Switzerland Stephen B. Milligan Kay Lawton Dale Skalla Address for Service: DAVIES COLLISON CAVE, Patent Trademark Attorneys, of 1 Nicholson Street, Melbourne, 3000, Victoria, Australia Ph: 03 9254 2777 Fax: 03 9254 2770 Attorney Code: DM "Promoters for regulation of gene expression in plant roots" Invention Title: The following statement is a full description of this invention, including the best method of performing it known to us:- P OPERTDO'024414U drv pgl d-oc- 11/I (K17 0 -1- M PROMOTERS FOR REGULATION OF GENE EXPRESSION IN PLANT ROOTS This application is a divisional application of Australian Application No. 2002354015 the ,i specification and drawings of which as originally filed are incorporated herein in their 0 entirety by reference.
FIELD OF THE INVENTION [0001] The present invention relates generally to the field of plant molecular biology and the regulation of gene expression in plants. More specifically, the present invention relates to the regulation of gene expression in plant roots.
BACKGROUND OF THE INVENTION [0002] Manipulation of crop plants to alter and/or improve phenotypic characteristics (such as productivity or quality) requires the expression of heterologous genes in plant tissues. Such genetic manipulation has become possible by virtue of two discoveries: the ability to transform heterologous genetic material into a plant cell and by the existence of promoters that are able to drive the expression of the heterologous genetic material).
[0003] It is advantageous to have the choice of a variety of different promoters so as to give the desired effect in the transgenic plant. Suitable promoters may be selected for a particular gene, construct, cell, tissue, plant or environment. Promoters that are useful for plant transgene expression include those that are inducible, viral, synthetic, constitutive (Odell et al., 1985, Nature 313: 810-812; Granger Cyr, 2001, Plant Cell Repo. 20: 227- 234), temporally regulated, spatially regulated, tissue-specific, and spatio-temporally regulated (Kuhlemeier et al. 1987, Ann. Rev. Plant Physiol. Plant Mol. Biol. 38: 221-257).
Promoters from bacteria, fungi, viruses and plants have been used to control gene expression in plant cells.
P OPERTDO 02144 140 dlv pgs doc- I lW'21X)7 la- [0004] Promoters consist of several regions that are necessary for full function of the promoter. Some of these regions are modular, in other words they can be used in isolation to confer promoter activity or they may be assembled with other elements to construct new promoters. The first of these promoter regions lies immediately upstream of the coding 0 0 sequence and forms the "core promoter region" containing consensus sequences, normally S20-70 base pairs immediately upstream of the coding sequence. The core promoter region contains a TATA box and often an initiator element as well as the initiation site. The precise length of the core promoter region is not fixed but is usually, WO 03/040322 PCTIUSO2/35374 well recognizable. Such a region is normally present, with some variation, in most N- promoters. The base sequences lying between the various well-characterized elements appear to be of lesser importance. The core promoter region is often referred to as a minimal promoter region because it is functional on its own to promote a basal level of transcription.
[00051 -The presence of the core promoter region defines a sequence as being a promoter: if the-region is absent, the promoter is non-functional. The core region acts to attract the 00 general transcription machinery to the promoter for transcription initiation. However, the core promoter region is insufficient to provide full promoter activity. A series of regulatory sequences, often upstream of the core, constitute the remainder of the promoter. The regulatory sequences determine expression level, the spatial and temporal pattern of expression and, for a subset of promoters, expression under inductive conditions (regulation by external factors such as light, temperature, chemicals and hormones). Regulatory sequences may be short regions of DNA sequence 6-100 base pairs that define the binding sites for trans-acting factors, such as transcription factors.
Regulatory sequences may also be enhancers, longer regions of DNA sequencc that can act from a distance from the core promoter region, sometimes over several kilobases from the core region. Regulatory sequence activity may be influenced by trans-acting factors including general transcription machinery, transcription factors and chromatin assembly factors.
100061 Frequently, it is desirable to have tissue-specific expression of a gene of interest in a plant. Tissue-specific promoters promote expression exclusively in one set of tissues without expression throughout the plant; tissue-preferred promoters promote expression at a higher level in a subset of tissues with significantly less expression in the othier tissues of the plant. For example, one may desire to express a value-added product only in corn seed but not in the remainder of the plant. Another example is the production of male sterility by tissue-specific ablation. In this case, a phytotoxic product is expressed only in the male tissue of the plant to ablate that specific tissue while othe r tissues of the flower. as well as the rest of the plant remain intact. Many aspects of agricultural biotechnology use and require tissue-specific expression.
[00071 One important example of a need for promoters is for the expression of selected genes in plant roots. The plant root consists of many cell types such as epidermal, root cap, columella, cortex, pericycle, vascular and root hair forming trichoblasts, organized WO 03/040322 PCT/US02/35374 into tissues or regions of the root, for example, the root tip, root epidermis, meristematic O zone, primary root, lateral root, root hair, and vascular tissue. Promoters isolated as rootspecific or root-preferred can be biased towards promotion ofexpression in one or a few Sof these cell types. This cell-specific activity can be useful for specific applications such i as regulating meristematic activity in only the meristematic cell zone or expression of a nematicidal gene in only the cell types that are contacted by the nematode pest. In other cases, broader cell-type specificity may be desired to express genes of interest throughout 00 the root tissue. This may be useful in expressing an insecticidal gene to control an insect Spest that feeds on plant roots, for instance corn rootworm (Diabrotica spp.). Broader celltype root specificity may be accomplished with a single root-specific promoter with broad cell-type specificity or by using two or more root-specific or root-preferred promoters of
C
different cell-type specificities for expression. A limited number of examples of rootpreferred and root-specific promoters have been described. These include the RB7 promoter from Nicotiana tabacum Pat. Nos. 5,459,252 and 5,750,386); the ARSKI promoter from Arabidopsis thaliana (Hwang and Goodman (1995) Plant J 8:37-43), the MR7 promoter from Zea mays Pat. No. 5,837,848), the ZRP2 promoter of Zea mays Pat. No. 5,633,363), and the MTL promoter from Zea mays Pat. Nos.
5,466,785 and 6,018,099). Many of these examples disclose promoters with expression patterns confined to a limited number of root tissues. Others fail to provide the rootspecificity needed for expression of selected genes. Thus, there is a need in the art for isolation and characterization of new root promoters to obtain those of different breadth, expression level and specificity of cell-type expression for root-specific and rootpreferred expression, particularly for root-specific expression.
SUMMARY OF THE INVENTION [00081 Within the present invention, compositions and methods for directing root-specific expression in transgenic plants are provided. In particular, novel nucleic acid molecules isolated from Zea mays, that drive expression ofheterologous genes in a root-specific manner in plants, are provided. The invention is lirtlher drawn to expression cassettlles nd vectors comprising the novel nucleic acid molecules of the invention operably linked to heterologous coding sequences. The invention is still further drawn to transgenic plants comprising the expression cassettes of the invention. The present invention also provides methods for specifically expressing a heterologous coding sequence in transgenic plant WO 03/040322 PCT/US02/35374 roots, for isolating a root-specific cDNA, for isolating a nucleic acid molecule useful for directing root-specific expression and for isolating a root-specific promoter. The Sinvention further provides primers and nucleic acid probes to identify related nucleotide sequences from other plant genomes that direct root-specific or root-preferred transcription.
[0009] According to one aspect, the present invention provides an isolated nucleic acid N molecule which codes for a promoter capable of directing root-specific transcription in a 00 plant, wherein the nucleotide sequence of the promoter comprises a nucleotide sequence Sselected from the group consisting of: a nucleotide sequence of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, or SEQ ID NO: 4; a nucleotide sequence that hybridizes Sunder high stringency conditions to a nucleotide sequence of and a nucleotide sequence comprising a fragment of a sequence of(a), wherein the fragment maintains function of the nucleotide sequence of [0010] In another aspect, the present invention provides fragments of the nucleotide sequences set forth in SEQ ID NOS: 1-4 wherein the fragments code for promoters capable of directing root-specific transcription in a plant. In a preferred embodiment of this aspect, the fragm'ents are made by making 5'-deletions in the nucleotide sequences set forth in SEQ ID NOS: 1-4. More preferably the fragment is a 5'-deletion of the nucleotide sequence set forth in SEQ ID NO: 1 or SEQ ID NO: 2.
[0011] The present invention also provides an expression cassette comprising the nucleic acid molecule of the invention operably linked to a heterologous coding sequence. In one embodiment, the expression cassette comprises a heterologous coding sequence selected from the group consisting of insecticidal coding sequences, nematicidal coding sequences, herbicide-tolerance coding sequences, anti-microbial coding sequences, antifungal coding sequences, anti-viral coding sequences, abiotic stress tolerance coding sequences, nutritional quality coding sequences, visible marker coding sequences and selectable marker coding sequences. In a preferred embodiment, the expression cassette comprises an insecticidal coding sequence that encodes a toxin active against a coleopteran pest. In a preferred aspect of this embodiment, the coleopteran pest is a species in the genus Diabrotica. In yet another embodiment, the expression cassette comprises an abiotic stress tolerance coding sequence including but not limited to drought stress, nutrient stress, salt stress, water stress and heavy metal stress. In still another embodiment, the expression cassette comprises a visible marker coding sequence WO 03/040322 PCT/US02/35374 including but not limited to green fluorescent protein (GFP), p-glucuronidase (GUS), and luciferase (LUC). In yet another embodiment, the expression cassette comprises a Sselectable marker coding sequence including but not limited to phosphomannose n isomerase (PMI), an antibiotic resistance gene such as hygromycin, kanamycin and the S like, a herbicide tolerance gene such as phosphinothricin and the like and bamase (bar).
[0012] The present invention also provides a recombinant vector comprising the C. expression cassette of the invention. In a preferred embodiment, the recombinant vector is 00 a plasmid.
O [00131 Further, the present invention provides a transgenic non-human host cell comprising the expression cassette of the invention. A transgenic host cell according to 0 this aspect of the invention is preferably a plant cell. Even further, the present invention provides a transgenic plant comprising such a transgenic plant cell. A transgenic plant according to this aspect of the invention may be sorghum, wheat, sunflower, tomato, cole crops, cotton, rice, soybean, sugar beet, sugarcane, tobacco, barley, oilseed rape and maize, preferably maize or rice. Still further, the present invention provides transgenic seed from the group of transgenic plants consisting of sorghum, wheat, sunflower, tomato, cole crops, cotton, rice, soybean, sugar beet, sugarcane, tobacco, barley, oilseed rape and maize. In a particularly preferred embodiment, the transgenic seed is from a transgenic maize plant or rice plant.
[0014] In another aspect, the present invention provides a method of specifically expressing a heterologous coding sequence in transgenic plant roots under transcriptional control of a nucleic acid mocloulo orthe invention, comprising: trnnsrorming plnnt cells with a vector wherein the vector comprises the nucleic acid molecule of the invention operably linked to a heterologous coding sequence, growing the transgenic plant cells comprising the vector, and producing transgenic plants from the transformed plant cells wherein the heterologous coding sequence is specifically expressed in plant roots under control of a nucleic acid molecule of the invention. In one embodiment of this aspect, the transgenic plant is a maize plant or a rice plant. In another embodiment of this aspect, the heterologous coding sequence is selected from the group consisting of insecticidal coding sequences, nematicidal coding sequences, herbicide tolerance coding sequences, anti-microbial coding sequences, anti-fungal coding sequences, anti-viral coding sequences, abiotic stress tolerance coding sequences, nutritional quality coding sequences, visible marker coding sequences and selectable WO 03/040322 PCT/US02/35374 marker coding sequences. In yet another embodiment, the invention provides ti~sgenic plants produced according to this aspect. In a preferred embodiment the transgenic plants Sare maize plants or rice plants.
n [0015] In a further aspect, the present invention provides a method of isolating a promoter capable of directing root-specific expression in plants comprising: preparing a nucleic acid probe from any one of SEQ ID NOS: 1-4; hybridizing the nucleic acid probe to either cDNA or genomic DNA prepared from a plant; and isolating a 00 *hybridizing sequence from the cDNA or the genomic DNA with at least 70% identity to Sthe nucleic acid probe.
S [0016] In another aspect, the present invention provides a method of identifying Sfragments of a promoter capable of directing root-specific expression in plants comprising: providing the isolated promoter sequence according to the invention; (b) generating fragments of the promoter sequence of step transforming plants with the fragments of step operably linked to a heterologous coding sequence; and (d) identifying the fragments of step having promoter activity in a transgenic plant by expression of the heterologous coding sequence.
[0017] Also provided by the present invention is a primer comprising at least 16 contiguous nucleotides of any one of SEQ ID NOS: 1-4. Further, the present invention provides a hybridization probe comprising at least 50 contiguous nucleotides of any one of SEQ ID NOS: 1-4.
BRIEF DESCRIPTION OF THE SEQUENCES IN THE SEQUENCE LISTING SEQ ID NO: 1 is the nucleotide sequence of the MRS promoter.
SEQ ID NO: 2 is the nucleotide sequence of the MRS2 promoter.
SEQ ID NO: 3 is the nucleotide sequence of the MRS3 promoter.
SEQ ID NO: 4 is the nucleotide sequence of the MRS4 promoter.
SEQ ID NO: 5 is the sequence of the root-specific cDNA designated 22P8.
SEQ ID NO: 6 is the predicted amino acid sequence encoded by SEQ ID NO: SEQ ID NO: 7 is the sequence of the root-specific cDNA designated 10B21.
SEQ ID NO: 8 is the predicted amino acid sequence encoded by SEQ ID NO: 7.
SEQ ID NO: 9 is the sequence of the root-specific cDNA designated 2D14.
SEQ ID NO: 10 is the predicted amino acid sequence encoded by SEQ ID NO: 9.
SEQ ID NO: 11 is the sequence of the root-specific cDNA designated 4H19.
WO 03/040322 PCT/US02/35374 SEQ ID NO: 12 is the predicted amino acid sequence encoded by SEQ ID NO: 11.
O SEQ ID NOS: 13-16 are primers useful in isolating 22P8 cDNA and related sequences.
CI SEQ ID NOS: 17-20 are primers useful in isolating 10B21 cDNA and related sequences.
SEQ ID NOS: 21-22 are primers useful in isolating 2D14 cDNA and related sequences.
In SEQ ID NOS: 23-26 are primers useful in isolating 4H19 cDNA and related sequences.
SEQ ID NO: 27 is an adapter primer useful according to the present invention.
C'1 SEQ ID NO: 28 is a primer useful in isolating the 22P8 promoter and related sequences.
0C SEQ ID NOS: 29-30 are primers useful in isolating the 10B21 promoter and related
N
Ssequences.
S SEQ ID NOS: 31-32 are primers useful in isolating the 2D14 promoter and related Ssequences.
CI SEQ ID NOS: 33-34 are primers useful in isolating the 4H19 promoter and related sequences.
SEQ ID NO: 35 is an adapter primer useful according to the present invention.
SEQ ID NO: 36 is the 22P8GSP7 forward primer.
SEQ ID NO: 37 is a 5' arm primer.
SEQ ID NO: 38 is a 3' X arm primer.
SEQ ID NOS: 39-40 are primers useful in amplifying the MRS 1L promoter.
SEQ ID NOS: 41-42 are primers useful in adding att sites to the MRS1L promoter.
SEQ ID NOS: 43-44 are primers useful in adding attB1 and attB2 sites to the 5' and 3' ends of the promoters of the present invention.
SEQ ID NO: 45 is a primer useful in amplifying the MRS1S promoter.
SEQ ID NO: 46 is a primer useful adding att sites to the MRS IS promoter.
SEQ ID NOS: 47-50 are primers useful in amplifying the MRS2 promoter.
SEQ ID NOS: 51-52 are primers useful in adding att sites to the MRS2 promoter.
SEQ ID NOS: 53-54 are primers useful in umplilying the MRS3 promoter.
SEQ ID NOS: 55-56 are primers useful in adding att sites to the MRS3 promoter.
SEQ ID NOS: 57-59 are primers useful in amplifying the MRS4 promoter.
SEQ ID NOS: 60-61 are primers useful in adding att sites to the MRS4 promoter.
SEQ ID NOS: 62-63 are primers useful in constructing a binary destination vector according to the present invention.
SEQ ID NOS: 64-67 are primers useful in isolating the MRS2M and MRS2S promoters.
WO 03/040322 PCT/US02/35374
DEFINITIONS
CN [00181 "Antisense inhibition" refers to the production of antisense RNA transcripts capable of suppressing the expression of protein from an endogenous gene or a transgene.
[0019] "Chimeric" is used to indicate that a DNA sequence, such as a vector or a gene, is comprised of two or more DNA sequences of distinct origin that are fused together by recombinant DNA techniques resulting in a DNA sequence, which does not occur 0 naturally.
00 N [0020] "Chromosomally-integrated" refers to the integration of a foreign gene or DNA
O
CN construct into the host DNA by covalent bonds. Where genes are not "chromosomally 0 integrated" they may be "transiently expressed." Transient expression of a gene refers to Cr the expression of a gene that is not integrated into the host chromosome but functions independently, either as part of an autonomously replicating plasmid or expression cassette, for example, or as part of another biological system such as a virus.
[0021] "Coding sequence" refers to a DNA or RNA sequence that codes for a specific amino acid sequence and excludes the non-coding sequences. It may constitute an "uninterrupted coding sequence", lacking an intron, such as in a cDNA or it may include one or more introns bounded by appropriate splice junctions. An "intron" is a sequence of RNA which is contained in the primary transcript but which is removed through cleavage and re-ligation of the RNA within the cell to create the mature mRNA that can be translated into a protein.
[0022] "Constitutive promoter" refers to a promoter that is able to express the gene that it controls in all or nearly all of the plant tissues during all or nearly all developmentalstages of the plant, thereby generating "constitutive expression" of the gene.
[00231 "Co-suppression" and "sense suppression" refer to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially identical transgene or endogenous genes Patent No. 5,231,020).
[0024] "Contiguous" is used herein to mean nucleic acid sequences that are immediately preceding or following one another.
[0025] "Corn rootworm" or "corn rootworms", as used herein, refer to insects of the genus Diabrotica, including the southern corn rootworm, the northern corn rootworm, the western corn rootworm, and the Mexican corn rootworm either in the larval or adult stage, preferably in the larval stage. The root-specific promoters of the invention are used
I
I
WO 03/040322 PCT/US02/35374 Sto express corn rootworm toxins in the roots of transgenic plants thus protecting fields of 1 transgenic plants from corn rootworm damage. The term "corn rootworm" and Diabrotica Sare herein used interchangeably.
[0026] "Expression" refers to the transcription and stable accumulation ofmRNA.
Expression may also refer to the production of protein.
(00271 "Expression cassette" as used herein means a DNA sequence capable of directing 0 expression of a particular nucleotide sequence in an appropriate host cell, comprising a 00 C promoter operably linked to the nucleotide sequence of interest which is operably linked C- to termination signals. It also typically comprises sequences required for proper Stranslation of the nucleotide sequence. The coding region usually codes for a protein of C- interest but may also code for a functional RNA of interest, for example antisense RNA or a nontranslated RNA, in the sense or antisense direction. The expression cassette comprising the nucleotide sequence of interest may be chimeric, meaning that at least one of its components is heterologous with respect to at least one of its other components.
10028] The "expression pattern" of a promoter (with or without an enhancer) is the pattern of expression level that shows where in the plant and in what developmental stage the promoter initiates transcription. Expression patterns of a set of promoters are said to be complementary when the expression pattern of one promoter shows little overlap with the expression pattern of the other promoter.
[0029) "Gene" refers to a nucleic acid fragment that expresses mRNA, functional RNA, or specific protein, including regulatory sequences. The term "Native gene" refers to a gene as found in nature. The term "chimeric gene" refers to any gene that contains 1) DNA sequences, including regulatory and coding sequences, that are not found togethur in nature, or 2) sequences encoding parts of proteins not naturally adjoined, or 3) parts of promoters that are not naturally adjoined. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or comprise regulatory sequences and coding sequences derived from the same source, but arranged in a manner different from that found in nature. A "transgene" refers to a gene that has been introduced into the genome by transformation and is stably maintained.
Transgenes may include, for example, genes that are either heterologous or homologous to the genes of a particular plant to be transformed. Additionally, transgenes may comprise native genes inserted into a non-native organism, or chimeric genes. The term "endogenous gene" refers to a native gene in its natural location in the genome of an WO 03/040322 PCT/US02/35374 organism. A "foreign" gene refers to a gene not normally found in the host organism but 0 O one that is introduced into the organism by gene transfer.
100301 "Gene silencing" refers to homology-dependent suppression of viral genes, transgenes, or endogenous nuclear genes. Gene silencing may be transcriptional, when the suppression is due to decreased transcription of the affected genes, or post-transcriptional, when the suppression is due to increased turnover (degradation) of RNA species homologous to the affected genes. (English, et al., 1996, Plant Cell 8:179-1881). Gene 00 silencing includes virus-induced gene silencing (Ruiz et al., 1998, Plant Cell 10:937-946).
C [00311 "Genetically stable" and "heritable" refer to chromosomally-integrated genetic elements that are stably maintained in the plant and stably inherited by progeny through successive generations.
C [0032] "Heterologous DNA Sequence" is a DNA sequence not naturally associated with a host cell into which it is introduced, including non-naturally occurring multiple copies of a naturally occurring DNA sequence.
[0033] "Inducible promoter" refers to those regulated promoters that can be turned on in one or more cell types by an external stimulus, such as a chemical, light, hormone, stress, or a pathogen.
[0034] "Insecticidal" is defined as a toxic biological activity capable of controlling insects, preferably by killing them.
[0035] non-coding sequence" refers to a nucleotide sequence located 5' (upstream) to the coding sequence. It is present in the fully processed mRNA upstream of the initiation codon and may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. (Turner et al., 1995, Molecular Biotechnology, 3:225).
[0036] non-coding sequence" refers to nucleotide sequences located 3' (downstream) to a coding sequence and include polyadenylation signal sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression.
The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor. The use of different 3' noncoding sequences is exemplified by Ingelbrecht et al. (1989, Plant Cell, 1:671-680,).
[0037] The term "nucleic acid" refers to a polynucleotide of high molecular weight which can be single-stranded or double-stranded, composed of monomers (nucleotides) containing a sugar, phosphate and a base which is either a purino or pyrimidtln. A "nucleic acid fragment" is a fraction of a given nucleic acid molecule. In higher plants,, WO 03/040322 PCT/US02/35374 deoxyribonucleic acid (DNA) is the genetic material while ribonucleic acid (RNA) is Sinvolved in the transfer of information contained within DNA into proteins. A "genome" Sis the entire body of genetic material contained in each cell of an organism. The term "nucleotide sequence" refers to a polymer of DNA or RNA which can be single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases capable of incorporation into DNA or RNA polymers.
N [00381 The terms "open reading frame" and "ORF" refer to the amino acid sequence 00 encoded between translation initiation and termination codons of a coding sequence. The Sterms "initiation codon" and "termination codon" refer to a unit of three adjacent nucleotides ('codon') in a coding sequence that specifies initiation and chain termination, 0respectively, of protein synthesis (mRNA translation).
[0039] "Operably-linked" and "Operatively-linked" refer to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other. For example, a promoter is operably-linked with a coding sequence or functional RNA when it is capable of affecting the expression of that coding sequence or functional RNA that the coding sequence or functional RNA is under the transcriptional control of the promoter). Coding sequences in sense or antisense orientation can be operably-linked to regulatory sequences.
[0040] "Overexpression" refers to the level of expression in transgenic organisms that exceeds levels of expression in normal or untransformed organisms.
[0041] "Plant tissue" includes differentiated and undifferentiated tissues or plants, including but not limited to roots, stems, shoots, leaves, pollen, seeds, tumor tissue and various forms of cells and culture such as single cells, protoplast, embryos, and callus tissue. The plant tissue may be in plants or in organ, tissue or cell culture.
[00421 "Preferred expression" is the expression of gene products that are preferably expressed at a higher level in one or a few plant tissues (spatial limitation) and/or to oll or a few plant developmental stages (temporal limitation) while in other tissues/developmental stages there is a relatively low level of expression.
[0043] "Primary transformant" and "TO generation" refer to transgenic plants that are of the same genetic generation as the tissue that was initially transformed not having gone through meiosis and fertilization since transformation). "Secondary transformants" and the "Tl, T2, T3, etc. generations" refer to transgenic plants derived from primary transformants through one or more meiotic and fertilization cycles. They may be derived
I
WO 03/040322 PCT/US02/35374 1^ by self-fertilization of primary or secondary transformants or crosses of primary or O secondary transformants with other transformed or untransformed plants.
10044] The terms "protein," "peptide" and "polypeptide" are used interchangeably herein.
S [00451 "Promoter" refers to a nucleotide sequence, usually upstream to its coding sequence, which controls the expression of the coding sequence by providing the recognition for RNA polymerase and other factors required for proper transcription.
IN "Promoter regulatory sequences" consist of proximal and more distal upstream elements, 0 the latter elements often referred to as enhancers. Accordingly, an "enhancer" is a DNA Ssequence that can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue specificity of a promoter. It is capable of operating in both orientations (normal or flipped), and is capable of functioning even when moved either upstream or downstream from the promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even be comprised of synthetic DNA segments. A "minimal or core promoter" is a promoter consisting only of all basal elements needed for transcription initiation, such as a TATAbox and/or initiator.
[0046] "Reference sequence" as used herein is defined as a sequence that is used as a basis for sequence comparison. A reference sequence may be a subset or the entirety of a specified sequence; for example, as a fragment of a full-length cDNA or gene sequence, or the full-length cDNA or gene sequence.
[00471 "Regulated promoter" refers to promoters that direct gene expression not constitutively, but in a temporally- and/or spatially-regulated manner, and include both tissue-specific and inducible promoters. It includes natural and synthetic sequences as well as sequences which may be a combination of synthetic and natural sequences.
Different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions.
[00481 "Regulatory sequences" nnd "suitnble regucilnory se quoncoH" oaicl ruolr to nucleotide sequences located upstream non-coding sequences), within, or downstream non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translition of the iiaociated coding Ncqutonce. Roguln(ory sequences include enhancers, promoters, translation leader sequences, introns, and WO 03/040322 PCT/US02/35374 polyadenylation signal sequences. They include natural and synthetic sequences as well S as sequences which may be a combination of synthetic and natural sequences.
[0049] The term "RNA transcript" refers to the product resulting from RNA polymerase Scatalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived by posttranscriptional processing of the primary transcript and is referred to as the mature RNA. "Messenger RNA" (mRNA) refers to the 00 RNA that is without introns and that can be translated into protein by the cell. "cDNA" Srefers to a single- or a double-stranded DNA that is complementary to and derived from mRNA. A "functional RNA" refers to an antisense RNA, ribozyme, or other RNA that is not translated. (but participates in a reaction or process as an RNA).
[0050] A "selectable marker gene" refers to a gene whose expression in a plant cell gives the cell a selective advantage. The selective advantage possessed by the cells transformed with the selectable marker gene may be due to their ability to grow in presence of a negative selective agent, such as an antibiotic or a herbicide, compared to the ability to grow of non-transformed cells. The selective advantage possessed by the transformed cells may also be due to their enhanced capacity, relative to non-transformed cells, to utilize an added compound as a nutrient, growth factor or energy source. A selective advantage possessed by a transformed cell may also be due to the loss of a previously possessed gene in what is called "negative selection". In this, a compound is added that is toxic only to cells that did not lose a specific gene (a negative selectable marker gene) present in the parent cell (typically a transgene).
[0051] "Specific expression" is the expression of gene products that is limited to one or a few plant tissues (spatial limitation) and/or to one or a few plant developmental stages (temporal limitation).
[0052] Substantially identical: the phrase "substantially identical," in the context of two nucleic acid or protein sequences, refers to two or more sequences or subsequences that have at least 60%, preferably 80%, more preferably 90, even more preferably 95%, and most preferably at least 99% nucleotide or amino acid residue identity, when compared and aligned for maximum correspondence, as measured using one of the following sequence comparison algorithms or by visual inspection. Preferably, the substantial identity exists over a region of the sequences that is at least about 50 residues in length, more preferably over a region of at least about 100 residues, and most preferably the WO 03/040322 PCT/US02/35374 sequences are substantially identical over at least about 150 residues. In an especially Spreferred embodiment, the sequences are substantially identical over the entire length of Ithe coding regions. Furthermore, substantially identical nucleic acid or protein sequences perform substantially the same function.
[0053] For sequence comparison, typically one sequence acts as a reference sequence to which test sequences are compared. When using a sequence comparison algorithm, test and reference sequences are input into a computer, subsequence coordinates are 0C designated if necessary, and sequence algorithm program parameters are designated. The Ssequence comparison algorithm then calculates the percent sequence identity for the test sequence(s) relative to the reference sequence, based on the designated program Sparameters. Those of skill in the art understand that to avoid a high similarity to a reference sequence due to inclusion of gaps in the polynucleotide sequence a gap penalty is typically introduced and is subtracted from the number of matches.
[0054] Optimal alignment of sequences for comparison can be conducted, by the local homology algorithm of Smith Waterman, 1981, Adv. Appl. Math. 2: 482, by the homology alignment algorithm ofNeedleman Wunsch, 1970, J. Mol. Biol. 48: 443, by the search for similarity method of Pearson Lipman, 1988, Proc. Nat'l. Acad. Sci. 2444, by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, WI), or by visual inspection (see generally, Ausubel et al., infra).
[0055] One example of an algorithm that is suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., 1990, J. Mol. Biol, 215: 403-410. Software for performing BLAST analyses is publicly available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). This algorithm involves first identifying high scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence, which either match or satisfy some positive-valued threshold score T when aligned with a word of the same length in a database sequenco. T is roorrotd to niw tho noighborhood word score threshold (Altschul et al., 1990). These initial neighborhood word hits act as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. Cumulative scores are calculated using, for nucleotide sequenqes, WO 03/040322 PCT/US02/35374 the parameters M (reward score for a pair of matching residues; always 0) arid N (penalty score for mismatching residues; always For amino acid sequences, a scoring matrix is used to calculate the cumulative score. Extension of the word hits in Seach direction are halted when the cumulative alignment score falls off by the quantity X nfrom its maximum achieved value, the cumulative score goes to zero or below due to the accumulation of one or more negative-scoring residue alignments, or the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLASTN program (for nucleotide sequences) O uses as defaults a word length of 11, an expectation of 10, a cutoff of 100, and a comparison of both strands. For amino acid sequences, the BLASTP program uses as defaults a word length of 3, an expectation of 10, and the BLOSUM62 scoring matrix (see Henikoff& Henikoff, 1989, Proc. Natl. Acad. Sci. 89: 10915).
[0056] In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, Karlin Altschul, Proc. Natl. Acad. Sci. USA 90: 5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is (he smallest sum probability which provides an indication of the probability by which a match between two nucleotide or amino acid sequences would occur by chance. For example, a test nucleic acid sequence is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid sequence to the reference nucleic acid sequence is less than about 0.1, more preferably less than about 0.01, and most preferably less than about 0.001.
(0057] For purposes of the present invention, comparison of nucleotide sequences for determination of percent sequence identity to the promoter sequences disclosed herein is preferably made using the BlastN program (version 1.4.7 or later) with its default parameters or any equivalent program. By "equivalent program" is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by the preferred program.
[0058] Another indication that two nucleic acid sequences are substantially identical is that the two molecules hybridize to each other under stringent hybridization conditions.
The phrase "hybridizing specifically to" refers to the binding, duplexing, or hybridizing of a molecule only to a particular nucleotide sequence under stringent hybridization WO 03/040322 PCT/US02/35374 conditions when that sequence is present in a complex mixture total cellulai) of 0DNA or RNA. "Bind(s) substantially" refers to complementary hybridization between a Sprobe nucleic acid and a target nucleic acid and embraces minor mismatches that can be S accommodated by reducing the stringency of the hybridization media to achieve the n desired detection of the target nucleic acid sequence.
[0059] "Stringent hybridization conditions" and "stringent hybridization wash conditions" N in the context of nucleic acid hybridization experiments such as Southern and Northern 00 hybridizations are sequence dependent, and are different under different environmental Sparameters. Longer sequences hybridize specifically at higher temperatures. An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology-Hybridization with Nucleic Acid Probes part I chapter 2, "Overview of principles of hybridization and the strategy of nucleic acid probe assays", Elsevier, New York. Generally, high stringency hybridization and wash conditions are selected to be about 5*C lower than the thermal melting point (Tm) for the specific sequence at a defined ionic strength and pH. Typically, under high stringency conditions a probe will hybridize to its target subsequence, but to no other sequences.
[0060] The Tm is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Very high stringency conditions are selected to be equal to the Tm for a particular probe. An example of high stringency hybridization conditions for hybridization of complementary nucleic acids which have more than 100 complementary residues on a filter in a Southern or northern blot is 50% formamide with 1 mg ofheparin at 42"C, with the hybridization being carried out overnight. An example of very high stringency wash conditions is 0.1 5M NaCI at 72°C for about 15 minutes. An example of high stringency wash conditions is a 0.2x SSC wash at 65"C for 15 minutes (sec, Samilbrook, Infra, fIr n dtlucrilliml~ o l'S(I bfiITr).
Often, a high stringency wash is preceded by a low stringency wash to remove background probe signal. An example medium stringency wash for a duplex of, e.g., more than 100 nucleotidos, is lx SSC nt 45"C for 15 minuts. An uxnmple low Htriguilncy wash for a duplex of, more than 100 nucleotides, is 4-6x SSC at 40 0 C for 15 minutes.
For short probes about 10 to 50 nucleotides), high stringency conditions typically involve salt concentrations or less thun about 1.0 M Na ion, typically ulout 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3, and the temperature is.typically at WO 03/040322 PCT/US02/35374 least about 30"C. High stringency conditions can also be achieved with he addition of Sdestabilizing agents such as formamide. In general, a signal to noise ratio of 2x (or higher) than that observed for an unrelated probe in the particular hybridization assay indicates detection of a specific hybridization. Nucleic acids that do not hybridize to each In other under high stringency conditions are still substantially identical if the proteins that they encode are substantially identical. This occurs, for example, when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic S code.
00 S [0061] Low stringency conditions include hybridization with a buffer solution of 30 to formamide, 1 M NaC1, 1% SDS (sodium dodecyl sulphate) at 370C, and a wash in SIX to 2X SSC (20X SSC 3.0 M NaCI/0.3 M trisodium. citrate) at 50 to 55 0
C.
Exemplary moderate stringency conditions include hybridization in 40 to formamide, 1.0 M NaCI, 1% SDS at 370C, and a wash in 0.5X to IX SSC at 55 to 60 0
C.
Exemplary high stringency conditions include hybridization in 0% formamide, 1 M NaCI, 1% SDS at 370C, and a wash in 0. 1 X SSC at 60 to 650C.
[0062] The following are examples of sets of hybridization/wash conditions that may be used to clone homologous nucleotide sequences that are substantially identical to reference nucleotide sequences of the present invention: a reference nucleotide sequence preferably hybridizes to the rfecrenco nuclcotide sequence in 7% sodium dodccyl muIlfto (SDS), 0.5 M NaPO 4 1 mM EDTA at 500C with washing in 2X SSC, 0.1% SDS at 50 0
C,
more desirably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 1 mM EDTA at 500C with washing in IX SSC, 0.1% SDS at 500C, more desirably still in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 1 mM EDTA at 50°C with washing in 0.5X SSC, 0.1% SDS at 50°C, preferably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 1 mM EDTA at 500C with washing in 0.1X SSC, 0.1% SDS at 500C, more preferably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 1 mM EDTA at 500C with washing in 0.1X SSC, 0.1% SDS at [0063] Specificity is typically the function of post-hybridization washes, the critical factors being the ionic strength and temperature of the final wash solution. For DNA- DNA hybrids, the Tm can be approximated from the equation of Meinkoth and Wahl Anal. Biochem. 138:267-284 (1984); TM 81.50C 16.6 (log M) +0.41 0.61 form) 500/L; where M is the molarity of monovalent cations, %GC is the percentage of guanosine and cytosine nucleotides in the DNA, form is the percentage of formamidb WO 03/040322 PCT/US02/35374 in the hybridization solution, and L is the length of the hybrid in base pairs. The TM is 0 the temperature (under defined ionic strength and pH) at which 50% of a complementary target sequence hybridizes to a perfectly matched probe. T is reduced by about 1 C for each 1% of mismatching; thus, TM, hybridization, and/or wash conditions can be tIn adjusted to hybridize to sequences of the desired identity. For example, if sequences with are sought, the Tm can be decreased 10 0 C. Generally, high stringency conditions are selected to be about 19 0 C lower than the thermal melting point (Tm) for the 00 specific sequence and its complement at a defined ionic strength and pH. However, very high stringency conditions can utilize a hybridization and/or wash at 1, 2, 3, or 4 0 C lower than the thermal melting point moderately stringent conditions can utilize a 0hybridization and/or wash at 6, 7, 8, 9, or 10 0 C lower than the thermal melting point (Tm); low stringency conditions can utilize a hybridization and/or wash at 11, 12, 13, 14, 15, or 0 C lower than the thermal melting point Using the equation, hybridization and wash compositions, and desired T, those of ordinary skill will understand that variations in the stringency of hybridization and/or wash solutions are inherently described. If the desired degree of mismatching results in a T of less than 45 0 C (aqueous solution) or 32 0
C
(formamide solution), it is preferred to increase the SSC concentration so that a higher temperature can be used. An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology- Hybridization with Nucleic Acid Probes, Part 1, Chapter 2 (Elsevier, New York); and Ausubel et al., eds. (1995) Current Protocols in Molecular Biology, Chapter 2 (Greene Publishing and Wiley Interscience, New York). See Sambrook et al. (1989) Molecular Cloning: A Laborator Manual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, New York).
[0064] A further indication that two nucleic acid sequences or proteins are substantially identical is that the protein encoded by the first nucleic acid is immunologically cross reactive with, or specifically binds to, the protein encoded by the second nucleic acid.
Thus, a protein is typically substantially identical to a second protein, for example, where the two proteins differ only by conservative substitutions.
[0065] "Tissue-specific promoter" refers to regulated promoters that are not expressed in all plant cells but only in one or more cell types in specific organs (such as leaves, roots or seeds), specific tissues (such as embryo or cotyledon), or specific cell types (such as WO 03/040322 PCT/US02/35374 lr- leaf parenchyma or seed storage cells). These also include promoters that are temporally
O
O regulated, such as in early or late embryogenesis, during fruit ripening in developing Sseeds or fruit, in fully differentiated leaf, or at the onset of senescence.
S [0066] "Transactivating gene" refers to a gene encoding a transactivating protein. It can n encode a transcription factor. It can be a natural gene, for example, a plant transcriptional activator, or a chimeric gene, for example, when plant regulatory sequences are operably- 1 linked to the open reading frame of a transcription factor from another organism.
00 "Transactivating genes" may be chromosomally integrated or transiently expressed.
S"Trans-activation" refers to switching on of gene by the expression of another 17- (regulatory) gene in trans.
0 (0067] A "transcriptional cassette" will comprise in the direction of transcription, a transcriptional and translational initiation region, a DNA sequence of interest, and a transcriptional and translational termination region functional in plants. The termination region may be native with the transcriptional initiation region, may be native with the DNA sequence of interest, or may be derived from another source.
[0068] The "transcription initiation site" is the position surrounding the first nucleotide that is part of the transcribed sequence, which is also defined as position With respect to this site all other sequences of the gene and its controlling regions are numbered.
Downstream sequences further protein encoding sequences in the 3' direction) are denominated positive, while upstream sequences (mostly of the controlling regions in 'the direction) are denominated negative.
[0069] The term "transformation" refers to the transfer of a nucleic acid fragment into the genome of a host cell, resulting in genetically stable inheritance. "Transiently transformed" refers to cells in which transgenes and foreign DNA have been introduced (for example, by such methods as Agrobacterium-mediated transformation or biolistic bombardment), but not selected for stable maintenance. "Stably transformed" refers to cells that have been selected and regenerated on a selection media following transformation.
[0070] 'Transformed transgenic recombinant" refer to a host organism such as a bacterium or a plant into which a heterologous nucleic acid molecule has been introduced.
The nucleic acid molecule can be stably integrated into the genome of the host or the nucleic acid molecule can also be present as an extrachromosomal molecule. Such an extrachromosomal molecule can be auto-replicating. Transformed cells, tissues, or plants WO 03/040322 PCT/US02/35374 are understood to encompass not only the end product of a transformation procss, but 0also transgenic progeny thereof. A "non-transformed", "non-transgenic", or "nonrecombinant" host refers to a wild-type organism, a bacterium or plant, which does not contain the heterologous nucleic acid molecule.
In [0071] 'Transient expression" refers to expression in cells in which a virus or a transgene is introduced by viral infection or by such methods as Agrobacterium-mediated transformation, electroporation, or biolistic bombardment, but not selected for its stable O maintenance.
[0072] The term "translation leader sequence" refers to that DNA sequence portion of a gene between the promoter and coding sequence that is transcribed into RNA and is Spresent in the fully processed mRNA upstream of the translation start codon. The Stranslation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency.
[0073] "Vector" is defined to include, inter alia, any plasmid, cosmid, phage or Agrobacterium binary vector in double or single stranded linear or circular form which may or may not be self transmissible or mobilizable, and which can transform prokaryotic or eukaryotic host either by integration into the cellular genome or exist extrachromosomally autonomous replicating plasmid with an origin of replication).
Specifically included are shuttle vectors by which is meant a DNA vehicle capable, naturally or by design, of replication in two different host organisms, which may be selected from actinomycetes and related species, bacteria and eucaryotic higher plant, mammalian, yeast or fmngal cells).
[00741 "Visible marker" refers to a gene whose expression does not confer an advantage to a transformed cell but can be made detectable or visible. Examples of visible markers include but are not limited to p-glucuronidase (GUS), luciferase (LUC) and green fluorescent protein (GFP).
10075) "Wild-type" refers to the normal gene, virus, or organism found in nature without any known mutation.
DETAILED DESCRIPTION OF THE INVENTION Identification of root-specific genes, promoters and homologues.
WO 03/040322 PCT/US02/35374
F'I--
[0076] In many instances, it is desirable to spatially regulate the expression of a transgene I so as to be expressed only in plant root tissues. A promoter capable of directing expression in a specific or preferential manner can most expeditiously accomplish this I spatial regulation.
[0077] The present invention provides isolated nucleic acid molecules having a nucleotide sequence that directs root-specific transcription in a plant. Root-specific 0 promoters are isolated by identifying genes that are specifically expressed in root tissue 00 of a target plant and subsequently isolating the regulatory sequences of these genes. In N one method as further described in the examples below, a PCR-subtractive approach is Sused. Messenger RNA (mRNA) is isolated from maize root-tissue as well as from a combination of non-root tissues from maize, such as leaf, stem, and reproductive tissues.
Complimentary DNA (cDNA) is made from each mRNA population and subsequently each cDNA population is digested with a restriction enzyme. Adapter primers, short DNA sequences, are ligated to the 5' and 3' ends of root-specific cDNA. The rootspecific and non-root cDNA fragment populations are then hybridized and PCR is used to selectively amplify root-specific cDNA fragments which are not present in the non-root cDNA population and thus do not hybridize with the non-root cDNA fragment population. The amplified cDNA fragments represent fragments of root-specific genes.
Using this method root-specific fragments are obtained. Longer sequences, full-length or near full-length cDNA clones of these genes can be obtained by PCR techniques or hybridization. Using a technique known in the art as RACE (rapid amplification of cDNA ends), gene-specific primers are made to the 5' region of the known sequence of each root-specific fragment and PCR is performed on a root-specific cDNA library in which the 5' end of each cDNA of the library has been ligated to a short nucleotide adapter sequence. PCR is used to amplify the region between the gene-specific primer and the adapter sequence. Root-specific cDNA clones exemplified herein by SEQ ID NOS: 5, 7, 9, and 11, were obtained generally using this technique.
[0078] Promoter sequences are obtained by cloning the genomic sequences that are homologous to the root-specific cDNA sequences. Genomic sequences may be obtained by hybridization methods or by using PCR methods to extend the sequence in either the or 3' direction from the known sequence (sometimes referred to as "genome walking").
For example, to obtain genomic sequences 5' to the known sequence of the cDNA, WO 03/040322 PCT/US02/35374 primers are made to the sequence near the 5' end of the cDNA. A genomic library is Sconstructed with the 5' end of each genomic DNA sequence ligated to a short
C
oligonucleotide adapter. PCR with a primer hybridizing to the adapter sequence and a ;Z primer of a root-specific cDNA sequence allows amplification of a genomic sequence t residing 5' to the homologous sequence of the root-specific sequence. DNA sequences obtained from genome walking are sequenced and if additional 5' regions are desired, the process is repeated with primers now at the 5' end of the longest obtained clone.
0 Genomic sequences homologous to root-specific cDNA sequences are also obtained by c hybridization under high stringency conditions. High stringency conditions select for 6 hybridization of a probe made from a root-specific cDNA sequence to hybridize to its 0homologous sequence in the genomic DNA. The genomic DNA is comprised in a C genomic DNA library of 5-20 kb maize genomic DNA sequences in a lambda phage vector. Genomic clones that hybridize with the root-specific cDNA are isolated and sequenced.
[0079] The genomic clones may include intron sequences, not found in the mRNA or the cDNA clones. The genomic sequences may additionally comprise 5' untranslated sequences, 3' untranslated sequences, and 5' and 3' regulatory sequences. Promoter sequences are found within the genomic sequence 5' to the cDNA sequence. Genomic sequences are cloned which are homologous to the root-specific cDNA sequences.
Sequences that are 5' to. the sequence homologous to the cDNA sequence are herein referred to as the 5' flanking region which comprises the promoter region.
[0080] Promoter and other regulatory sequences are mapped by comparison of the genomic sequence with the homologous root-specific cDNA sequences as well as using sequence homology comparisons to locate the TATA box and other regulatory elements such as binding sites for known plant transcription factors (Guifoyle, TJ, 1997, Genetic Engineering 19: 15-47; Meisel and Lain, 1997, Genetic Engineering 19: 183-199).
Promoters exemplified herein are set forth in SEQ ID NOS: 1-4.
10081] In one embodiment of the invention, to further delineate the sequences required for root-expression as well as those regulatory sequences that influence the overall level of expression, deletions of the root-specific promoter regions are made. Deletions are made in the 5' flanking region of each root-specific clone. In most promoters 500-1000 base pairs (bp) of 5' flanking sequence are sufficient for promoter activity, including tissue-specific activity. Deletions of the 5' flanking region can result in promoter regiops WO 03/040322 PCT/US02/35374 of approximately 50 bp, 100 bp, 250 bp, 500 bp, 750 bp and 1000 bp or more. "These O promoter deletion sequences serve a two-fold purpose. The deletions allow the further mapping of regulatory sequences within the 5' flanking sequence of each root-specific genomic clone. Additionally, the deletions provide a toolbox of promoter and regulatory sequences that vary in their expression levels and expression patterns thus providing additional flexibility in choosing promoter sequences for appropriate gene regulation.
CI Exemplified herein are fully functional shorter fragments of a promoter designated MRS 1 00 (SEQ ID NO: 1) and a promoter designated MRS2 (SEQ ID NO: The fully functional S shorter fragment of MRS1 comprises nucleotides 603-1392 of SEQ ID NO: 1 and is designated MRS1S. One fully functional shorter fragment of MRS2 comprises Snucleotides 921-2869 of SEQ ID NO: 2 and is designated MRS2-M. Another fully functional shorter fragment of MRS2 comprises nucleotides 1913-2869 of SEQ ID NO: 2 and is designated MRS2-S.
[0082] It is also clear to one skilled in the art that mutations, insertions, deletions and/or substitutions of one or more nucleotides can be introduced into the nucleotide sequences of SEQ ID NOS: 1-4 using methods known in the art. In addition, shuffling the sequences of the invention can provide new and varied nucleotide sequences.
[0083] To test for a function of variant DNA sequences according to the invention, such as deletion fragments of SEQ ID NOS: 1-4, the sequence of interest is operably linked to a selectable or visible marker gene and expression of the marker gene is tested in transient expression assays with isolated root tissue or cells or by stable transformation into plants.
It is known to the skilled artisan that DNA sequences capable of driving expression of an associated coding sequence are built in a modular way. Accordingly, expression levels from shorter DNA fragments may be different than the one from the longest fragment and may be different from each other. For example, deletion of a down-regulating upstream element will lead to an increase in the expression levels of the associated coding sequence while deletion of an up-regulating element will decrease the expression levels of the associated coding sequence. It is also known to the skilled artisan that deletion of development-specific or a tissue-specific elements will lead to a temporally or spatially altered expression profile of the associated coding sequence.
[0084] In another embodiment of the invention, DNA and genomic DNA sequences homologous to SEQ ID NOS: 1-4 or SEQ ID NOS: 5, 7, 9, and 11 may be isolated from other maize germplasm using either hybridization or PCR techniques well known in thy 23 WO 03/040322 PCT/US02/35374 art. The isolated sequences may be identical to SEQ ID NOS: 1-4 or SEQ ID NOS: 5, 7, S9, and 11 or they may be substantially identical to SEQ ID NOS: 1-4 or SEQ ID NOS: S7, 9, and 11. It is not necessary for the sequences obtained from other maize germplasm to contain identical nucleotide sequences to be functionally identical to the sequences disclosed herein. Some nucleotide deletions, additions, and replacements may have no impact or only a minor impact on gene expression. A preferable isolated nucleic acid N molecule, according to the present invention, comprises a nucleotide sequence that has at 00 least 70% identity to any one of the nucleotide sequences set forth in SEQ ID NOS: 1-4.
O A more preferable isolated nucleic acid molecule comprises a nucleotide sequence that has at least 80% identity to any one of the nucleotide sequences set forth in SEQ ID NOS: O 1-4. An even more preferable isolated nucleic acid molecule comprises a nucleotide sequence that has at least 90% identity to any one of the nucleotide sequences set forth in SEQ ID NOS: 1-4. An even more preferable isolated nucleic acid molecule comprises a nucleotide sequence that has at least 95% identity to any one of the nucleotide sequences set forth in SEQ ID NOS: 1-4. An even more preferable isolated nucleic acid molecule comprises a nucleotide sequence that has at least 99% identity to any one of the nucleotide sequences set forth in SEQ ID NOS: 1-4. The most preferable isolated nucleic acid molecule comprises any one of the nucleotide sequences set forth is SEQ ID NOS: 1- 4.
[0085] In another embodiment of the invention, cDNA and genomic DNA sequences may be cloned from other plants that represent homologues of the root-specific maize genes and promoters. These homologues allow one to obtain additional root-specific promoters useful for the regulation of multiple genes in the root. Hybridization using the maize cDNA and genomic sequences or portions thereof is used to screen for homologous or substantially identical sequences in other plant genomes. These sequences may comprise only a subset orthe nucleotldcs orSIQ ID NOS: 1-4. A prolbrublu length ol'honlohgy in base pairs (bp) in length, more preferably, 50 bp in length, and most preferably at least 100 bp in length. In one embodiment of the present invention, a hybridization probe is prepared from any one SEQ ID NOS: 1-4 or portions thereof or SEQ ID NOS: 5, 7, 9, or 11 or portions thereof. Hybridization of such sequences may be carried out under high stringency conditions. Alternatively, low or moderate stringency conditions can be used to allow some mismatching in sequences so that lower degrees of similarity nre detected WO 03/040322 PCT/US02/35374 (heterologous probing). Generally, a probe is less than about 1000 nucleotides in*length, preferably less than 500 nucleotides in length.
100861 In another embodiment of the present invention, cDNA and genomic sequences n are isolated by preparing primers comprising sequences within any one of SEQ ID NOS: S1-4 or comprising primer sequences from SEQ ID NOS: 5, 7, 9, or 11. The primers may be used in a PCR reaction with cDNA or genomic DNA from a plant to obtain CM homologous sequences or sequences with substantial identity to any one of SEQ ID NOS:
O
00 1-4.
OC
NC Construction of Expression cassettes
O
S [0087] Expression cassettes are constructed comprising the 5' flanking sequences of the root-specific genomic clones. In one embodiment of the present invention, the promoter region utilized in each expression cassette comprises the 5' flanking region up to and including the start of translation. The start of translation is denoted by the first ATG of the open reading frame (ORF) found in the cDNA and the homologous genomic sequence. Thus, the promoter region may include 5' untranslated leader sequence as well as the transcriptional start site, core promoter and additional regulatory elements. In another embodiment of the present invention, expression cassettes are constructed comprising the 5' flanking sequence of the root-specific genomic clones up to and including the transcriptional initiation site. The transcriptional intiation site may be defined by the first nucleotide of the longest cDNA clone obtained. Additionally, the transcriptional intiation site may be further defined by use of techniques well known in the art including RACE PCR, RNase protection mapping and primer extension analysis.
(0088] The expression cassettes may further comprise a transcriptional terminator, downstream to the promoter. A variety of transcriptional terminators 1re avuilhbl for use in expression cassettes. The transcriptional terminator is responsible for the termination of transcription beyond the transgene and correct mRNA polyadenylation of the mRNA transcript. Appropriate transcriptional terminators are those that are known to function in plants and include the CaMV 35S terminator, the tml terminator, the nopaline synthase terminator and the pea rbcS E9 terminator. These can be used in both monocotyledons and dicotyledons. In addition, a gene's native transcription terminator WO 03/040322 PCT/US02/35374 may be used. For example, the 3' flanking sequence comprising genomic sequence 3' to the region homologous to a root-specific cDNA clone may be used.
a [0089] In a preferred embodiment of the present invention a heterologous coding sequence, for example, an insecticidal coding sequence, a visible marker coding sequence, or a selectable marker coding sequence, is cloned between a promoter of the.
invention and transcriptional terminator whereby the heterologous coding sequence is operatively linked to the promoter and the transcriptional terminator is operatively linked 0 0 to the heterologous coding sequence. Examples of visible markers useful for the present invention include, but are not limited to, p-glucuronidase (GUS), Chloramphenicol Acetyl Transferase (CAT), Luciferase (LUC) and proteins with fluorescent properties, 2 such as Green Fluorescent Protein (GFP) from Aequora victoria. In principle, many more proteins are suitable for this purpose, provided the protein does not interfere with essential plant functions. Further examples of heterologous coding sequences useful for the present invention include, but are not limited to, antibiotic resistance, virus resistance, insect resistance, disease resistance, or resistance to other pests, herbicide tolerance, improved nutritional value, improved performance in an industrial process or altered reproductive capability. In a preferred embodiment of the present invention, a gene encoding for resistance to insects that feed on the roots of the plant is cloned between the promoter and terminator. In another embodiment of the present invention a sequence encoding a functional RNA such as antisense RNA, a sense RNA for sense-suppression, or a double stranded RNA may also be cloned between the promoter and transcriptional terminator.
[0090] Numerous sequences have been found to enhance gene expression from within the transcriptional unit and these sequences can be used in conjunction with the promoters of this invention to increase their expression in transgenic plants. Various intron sequences have been shown to enhance expression, particularly in monocotyledonous cells. For example, the introns of the maize AdhI gene have been found to significantly enhance the expression of the wild-type gene under its cognate promoter when introduced into maize cells. Intron 1 was found to be particularly effective and enhanced expression in fusion constructs with the chloramphenicol acetyltransferase gene (Callis et al., Genes Develop.
1: 1183-1200 (1987)). In the same experimental system, the intron from the maize bronzel gene had a similar effect in enhancing expression, Intron csquences have been routinely incorporated into plant transformation vectors, typically within the non- I WO 03/040322 PCT/US02/35374 translated leader. A number of non-translated leader sequences derived from viruses are 0 also known to enhance expression, and these are particularly effective in dicotyledonous N cells. Specifically, leader sequences from Tobacco Mosaic Virus (TMV, the "Wsequence"), Maize Chlorotic Mottle Virus (MCMV), and Alfalfa Mosaic Virus (AMV) Shave been shown to be effective in enhancing expression Gallie et al. Nucl. Acids: Res. 15: 8693-8711 (1987); Skuzeski et al. Plant Molec. Biol. 15: 65-79 (1990)). Other leader sequences known in the art include but are not limited to: picomavirus leaders, for 0 example, EMCV leader (Encephalomyocarditis 5' noncoding region) (Elroy-Stein, O., Fuerst, T. and Moss, B. PNAS USA 86:6126-6130 (1989)); potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allison et al., 1986); MDMV leader (Maize SDwarf Mosaic Virus); Virology 154:9-20); human immunoglobulin heavy-chain binding I protein (BiP) leader, (Macejak, D. and Sarnow, Nature 353: 90-94 (1991); untranslated leader from the coat protein mRNA of alfalfa mosaic virus (AMV RNA 4), (Jobling, S. and Gehrke, Nature 325:622-625 (1987); tobacco mosaic virus leader (TMV), (Gallie, D. R. et al., Molecular Biology of RNA, pages 237-256 (1989); and Maize Chlorotic Mottle Virus leader (MCMV) (Lommel, S. A. et al., Virology 81:382- 385 (1991). See also, Della-Cioppa et al., Plant Physiology 84:965-968 (1987).
Plant Transformation Methods Useful for the Invention [0091] Numerous transformation vectors available for plant transformation are known to those of ordinary skill in the plant transformation art, and the nucleic acid molecules of the invention can be used in conjunction with any such vectors. The selection of vector will depend upon the preferred transformation technique and the target plant species for transformation. For ccrlnin target species, diffrcnt antibiotlic or hurbicide Holuetion markers may be preferred. Selection markers used routinely in transformation include the nptllgene, which confers resistance to kanamycin and related antibiotics (Messing Vierra. Gene 19: 259-268 (1982); Bevan et al., Nature 304:184-187 (1983)), the bar gene, which confers resistance to the herbicide phosphinothricin (White et al., Nucl. Acids Res 18: 1062 (1990), Spencer et al. Theor. Appl. Genet 79: 625-631 (1990)), the hph gene, which confers resistance to the antibiotic hygromycin (Blochinger Diggelmann, Mol Cell Biol 4: 2929-2931), and the dhfr gene, which confers resistance to methatrexate WO 03/040322 PCT/US02/35374 (Bourouis et al., EMBO J. 1099-1104 (1983)), the EPSPS gene, which confers Sresistance to glyphosate Patent Nos. 4,940,935 and 5,188,642), and the mannose-6- Sphosphate isomerase gene, which provides the ability to metabolize mannose Patent Nos. 5,767,378 and 5,994,629).
1 Vectors Suitable for Agrobacterium Transformation 0 [0092] Many vectors are available for transformation using Agrobacterium tumefaciens.
These typically carry at least one T-DNA border sequence and include vectors such as SpBIN19 (Bevan, Nucl. Acids Res. (1984)). Below, the construction of two typical vectors 1 suitable for Agrobacterium transformation is described.
pCIB200 and pCIB2001: [0093] The binary vectors pCIB200 and pCIB2001 are used for the construction of recombinant vectors for use with Agrobacterhum and are constructed in the following manner. pTJS75kan is created by Narl digestion ofpTJS75 (Schmidhauser Helinski, J.
Bacteriol. 164: 446-455 (1985)) allowing excision of the tetracycline-resistance gene, followed by insertion of an Accl fragment from pUC4K carrying an NPTII (Messing Vierra, Gene 19:259-268 (1982): Bevan et al., Nature 304: 184-187 (1983): McBride et al., Plant Molecular Biology 14: 266-276 (1990)). Xhol linkers are ligated to the EcoRV fragment of PCIB7 which contains the left and right T-DNA borders, a plant selectable nos/nptll chimeric gene and the pUC polylinker (Rothstein et al., Gene 53: 153-161 (1987)), and the Xhol-digested fragment are cloned into SaI/-digested pTJS75kan to create pCIB200 (see also EP 0 332 104, example 19). pCIB200 contains the following unique polylinker restriction sites: EcoRI, Sstl, Kpnl, BglII, XbaI, and Sail. pCIB2001 is a derivative of pCIB200 created by the insertion into the polylinker of additional restriction sites. Unique restriction sites in the polylinker of pCIB2001 are EcoRI, SstI, KpnI, BglII, Xbal, Sail, Mhul, BclI, AvrIl, Apal, Ipal, and Stud. pCIB2001, in addition to containing these unique restriction sites also has plant and bacterial kanamycin selection, left and right T-DNA borders for Agrobacterium-mediated transformation, the RK2derived trfA function for mobilization betwoon E. coll and other hoats, and the Or/'1 Tntl WO 03/040322 PCT/US02/35374 OriV functions also from RK2. The pCIB2001 polylinker is suitable for the cloning of Splant expression cassettes containing their own regulatory signals.
It pCIB10 and Hygromycin Selection Derivatives thereof: [0094] The binary vector pCIB10 (Rothstein et al. (Gene 53: 153-161 (1987)) contains a 0gene encoding kanamycin resistance for selection in plants and T-DNA right and left O0 border sequences and incorporates sequences from the wide host-range plasmid pRK252 allowing it to replicate in both E. coli and Agrobacterium. Various derivatives of that incorporate the gene for hygromycin B phosphotransferase are described by Gritz et al. (Gene 25: 179-188 (1983)). These derivatives enable selection of transgenic plant cells on hygromycin only (pCIB743), or hygromycin and kanamycin (pCIB715, pCIB717).
Vectors Suitable for non-Agrobacterlum Transformation [0095] Transformation without the use of Agrobacterium tumefaciens circumvents the requirement for T-DNA sequences in the chosen transformation vector and consequently vectors lacking these sequences can be utilized in addition to vectors such as the ones described above which contain T-DNA sequences. Transformation techniques that do not rely on Agrohacterium include tranarormntion vin particlo homhlrdmont, protopInt uptake PEG and electroporation) and microinjection. The choice of vector depends largely on the preferred selection for the species being transformed. Below, the construction of typical vectors suitable for non-Agrobacterlum transformation is described.
pCIB3064: [0096] pCIB3064 is a pUC-derived vector suitable for direct gene transfer techniques in combination with selection by the herbicide Basta (or phosphinothricin). The plasmid pCIB246 comprises the CaMV 35S promoter in operational fusion to the E. coil GUS WO 03/040322 PCT/US02/35374 gene and the CaMV 35S transcriptional terminator and is described in the PCT published N application WO 93/07278. The 35S promoter of this vector contains two ATG sequences of the start site. These sites are mutated using standard PCR techniques in such a way as to remove the ATGs and generate the restriction sites SspI and Pvull. The new irestriction sites are 96 and 37 bp away from the unique Sail site and 101 and 42 bp away from the actual start site. The resultant derivative ofpCIB246 is designated pCIB3025.
The GUS gene is then excised from pCIB3025 by digestion with Sail and Sac, the 00 termini rendered blunt and re-ligated to generate plasmid pCIB3060. The plasmid pJIT82 Sis obtained from the John Innes Centre, Norwich and the 400 bp SmaI fragment containing the bar gene from Streptomyces viridochromogenes is excised and inserted into the Hpalsite ofpCIB3060 (Thompson et al. EMBO J 6: 2519-2523 (1987)). This generated pCIB3064, which comprises the bar gene under the control of the CaMV promoter and terminator for herbicide selection, a gene for ampicillin resistance (for selection in E. coli) and a polylinker with the unique sites SphI, Pst, Hind!!, and BamHI.
This vector is suitable for the cloning of plant expression cassettes containing their own regulatory signals.
pSOG19 and I0100] pSOG35 is a transformation vector that utilizes the E. coli gene dihydrofolate reductase (DFR) as a selectable marker conferring resistance to methotrexate. PCR is used to amplify the 35S promoter (-800 bp), intron 6 from the maize Adhl gene (-550 bp) and 18 bp of the GUS untranslated leader sequence from pSOG1O. A 250-bp fragment encoding the E. coli dihydrofolate reductase type II gene is also amplified by PCR and these two PCR fragments are assembled with a Sacl-PstI fragment from pB1221 (Clontech) which comprises the pUC19 vector backbone and the nopaline synthase terminator. Assembly of these fragments generates pSOG19 that contains the promoter in fusion with the intron 6 sequence, the GUS leader, the DHFR gene and the nopaline synthase terminator. Replacement of the GUS leader in pSOG19 with the leader sequence from Maize Chlorotic Mottle Virus (MCMV) generates the vector pSOG19 and pSOG35 carry the pUC gene for ampicillin resistance and have HindlI, SphI, Pstl and EcoRI sites available for the cloning of foreign substances.
WO 03/040322 PCT/US02/35374 S Transformation Methods Useful for the Present Invention
O
[01011 Once a nucleic acid molecule of the invention has been cloned into an expression cassette, it is transformed into a plant cell. The receptor and target expression cassettes of Sthe present invention can be introduced into the plant cell in a number of art-recognized ways. Methods for regeneration of plants are also well known in the art. For example, Ti C plasmid vectors have been utilized for the delivery of foreign DNA, as well as direct 00 DNA uptake, liposomes, electroporation, microinjection, and microprojectiles. In Saddition, bacteria from the genus Agrobacterium can be utilized to transform plant cells.
Below are descriptions of representative techniques for transforming both dicotyledonous Sand monocotyledonous plants, as well as a representative plastid transformation technique.
[0102] Plants transformed in accordance with the present invention may be monocots or dicots and include, but are not limited to, maize, wheat, barley, rye, sweet potato, bean, pea, chicory, lettuce, cabbage, cauliflower, broccoli, turnip, radish, spinach, asparagus, onion, garlic, pepper, celery, squash, pumpkin, hemp, zucchini, apple, pear, quince, melon, plum, cherry, peach, nectarine, apricot, strawberry, grape, raspberry, blackberry, pineapple, avocado, papaya, mango, banana, soybean, tomato, sorghum, sugarcane, sugarbeet, sunflower, rapeseed, clover, tobacco, carrot, cotton, alfalfa, rice, potato, eggplant, cucumber, Arabidopsis thaliana, and woody plants such as coniferous and deciduous trees, especially maize, wheat, or sugar beet.
[0103] Once an expression cassette is transformed into a particular plant species, the expression cassette may be propagated in that species or moved into other varieties of the same species, particularly including commercial varieties, using traditional breeding techniques.
Transformation of Dicotyledons [01041 Transformation techniques for dicotyledons are well known in the art and include both Agrobacterium-based and non-Agrobacterium based techniques. Non- Agrobacterium techniques involve the uptake of exogenous genetic material directly by protoplasts or cells. This can be accomplished by particle bombardment-mediated WO 03/040322 PCT/US02/35374 delivery, microinjection, or PEG or electroporation mediated uptake. Examples f these techniques are described by Paszkowski et al., EMBO J 3: 2717-2722 (1984), Potrykus et al., Mol. Gen. Genet. 199: 169-177 (1985), Reich et al., Biotechnology 4: 1001-1004 (1986), and Klein et al., Nature 327: 70-73 (1987). In each case the transformed cells are regenerated to whole plants using standard techniques known in the art.
[0105] Agrobacterium-mediated transformation is a preferred technique for transformation of dicotyledons because of its high efficiency of transformation and its broad utility with many different species. Agrobacterium transformation typically involves the transfer of the binary vector carrying the foreign DNA of interest (e.g.
pCIB200 or pCIB2001) to an appropriate Agrobacterlum strain which may depend of the complement of vir genes carried by the host Agrobacterium strain either on a co-resident Ti plasmid or chromosomally strain CIB542 for pCIB200 and pCIB2001 (Uknes et al. Plant Cell 5: 159-169 (1993)). The transfer of the recombinant binary vector to Agrobacterium is accomplished by a tri-parental mating procedure using E. coli carrying the recombinant binary vector, a helper E. coli strain which carries a plasmid such as pRK2013 and which is able to mobilize the recombinant binary vector to the target Agrobacterium strain. Alternatively, the recombinant binary vector can be transferred to Agrobacterium by DNA transformation (H6fgen Willmitzer, Nucl. Acids Res. 16: 9877 (1988)).
[0106] Transformation of the target plant species by recombinant Agrobacterium usually involves co-cultivation of the Agrobacterium with explants from the plant and follows protocols well known in the art. Transformed tissue is regenerated on selectable medium carrying the antibiotic or herbicide resistance marker present between the binary plasmid T-DNA borders.
[01071 Another approach to transforming plant cells with a gene involves propelling inert or biologically active particles at plant tissues and cells. This technique is disclosed in U.S. Patent Nos. 4,945,050, 5,036,006, and 5,100,792 all to Sanford et al. Generally, this procedure involves propelling inert or biologically active particles at the cells under conditions effective to penetrate the outer surface of the cell and afford incorporation within the interior thereof. When inert particles are utilized, the vector can be introduced into the cell by coating the particles with the vector containing the desired gene.
Alternatively, the vector can surround the target coll so that the vector is carried into the cell by the wake of the particle. Biologically active particles dried yeast cells, dripd WO 03/040322 PCT/US02/35374 bacterium or a bacteriophage, each containing DNA sought to be introduced) can also be propelled into plant cell tissue.
t) Transformation of Monocotyledons 1 [0108] Transformation of most monocotyledon species has now also become routine.
0Preferred techniques include direct gene transfer into protoplasts using PEG or electroporation techniques, and particle bombardment into callus tissue. Transformations can be undertaken with a single DNA species or multiple DNA species co- Stransformation) and both these techniques are suitable for use with this invention. Co- Stransformation may have the advantage of avoiding complete vector construction and of generating transgenic plants with unlinked loci for the gene of interest and the selectable marker, enabling the removal of the selectable marker in subsequent generations, should this be regarded desirable. However, a disadvantage of the use of co-transformation is the less than 100% frequency with which separate DNA species are integrated into the genome (Schocher et al. Biotechnology 4:1093-1096 (1986)).
[01091 Patent Applications EP 0 292 435, EP 0 392 225, and WO 93/07278 describe techniques for the preparation of callus and protoplasts from an elite inbred line of mnize, transformation of protoplasts using PEG or electroporation, and the regeneration of maize plants from transformed protoplasts. Gordon-Kamm et al. (Plant Cell 2: 603-618 (1990)) and Fromm et al. (Biotechnology 8: 833-839 (1990)) have published techniques for transformation of A188-derived maize line using particle bombardment. Furthermore, WO 93/07278 and Koziel et al. (Biotechnology 11: 194-200 (1993)) describe techniques for the transformation of elite inbred lines of maize by particle bombardment. This technique utilizes immature maize embryos of 1.5-2.5 mm length uxciled from I inlmlzu ear 14-15 days after pollination and a PDS-l000He Biolistics device for bombardment.
[0110] Transformation of rice can also be undertaken by direct gene transfer techniques utilizing protoplasts or particle bombardment. Protoplast-mediated transformation has been described for Japonica-types and Indica-types (Zhang et al. Plant Cell Rep 7: 379- 384 (1988); Shimamoto et al. Nature 338: 274-277 (1989); Datta et al. Biotechnology 8: 736-740 (1990)). Both types are also routinely transformable using particle bombardment WO 03/040322 PCT/US02/35374 (Christouet al. Biotechnology 9: 957-962 (1991)). Furthermore, WO 93/21335 describes techniques for the transformation of rice via electroporation.
a [0111) Patent Application EP 0 332 581 describes techniques for the generation, transformation and regeneration ofPooideae protoplasts. These techniques allow the transformation ofDactylis and wheat. Furthermore, wheat transformation has been described by Vasil et al. (Biotechnology 10: 667-674 (1992)) using particle bombardment Sinto cells of type C long-term regenerable callus, and also by Vasil et al. (Biotechnology 00 11: 1553-1558 (1993)) and Weeks et al. (Plant Physiol. 102: 1077-1084 (1993)) using O particle bombardment of immature embryos and immature embryo-derived callus. A preferred technique for wheat transformation, however, involves the transformation of wheat by particle bombardment of immature embryos and includes either a high sucrose or a high maltose step prior to gene delivery. Prior to bombardment, embryos that are 0.75-1 mm in length are plated onto MS medium with 3% sucrose (Murashiga Skoog, Physiologia Plantarum 15: 473-497 (1962)) and 3 mg/1 2,4-D for induction of somatic embryos, which is allowed to proceed in the dark. On the chosen day of bombardment, embryos are removed from the induction medium and placed onto the osmoticum (i.e.
induction medium with sucrose or maltose added at the desired concentration, typically The embryos are allowed to plasmolyze for 2-3 h and are then bombarded.
Twenty embryos per target plate is typical, although not critical. An appropriate gcnecarrying plasmid (such as pCIB3064 or pSG35) is precipitated onto micrometer size gold particles using standard procedures. Each plate of embryos is shot with the DuPont Biolistics® helium device using a burst pressure of -1000 psi using a standard 80 mesh screen. After bombardment, the embryos are placed back into the dark to recover for about 24 h (still on osmoticum). After 24 hrs, the embryos are removed from the osmoticum and placed back onto induction medium where they stay for about a month before regeneration. Approximately one month later the embryo cxplants with developing embryogenic callus are transferred to regeneration medium (MS 1 mg/liter NAA, 5 mg/liter GA), further containing the appropriate selection agent (10 mg/1 basta in the case ofpCIB306 4 and 2 mg/1 methotrexate in the case ofpSOG35). After approximately one month, developed shoots are transferred to larger sterile containers known as "GA7s" which contain half-strength MS, 2% sucrose, and the same concentration of selection agent.
WO 03/040322 PCT/US02/35374 o [0112] Transformation of monocotyledons using Agrobacterium has also been described 0 in WO 94/00977 and U.S. Patent No. 5,591,616, both of which are incorporated herein by S, reference. A preferred method of maize transformation is described in Negrotto et al., n (Plant Cell Reports 19: 798-803 (2000)), incorporated herein by reference.
Analysis of promoter activity tO 00 N [0113] Several methods are available to assess promoter activity. Expression cassettes are constructed with a visible marker, as described above. Transient transformation Smethods are used to assess promoter activity. Using transformation methods such as N microprojectile bombardment, Agrobacterium transformation or protoplast transformation, expression cassettes are delivered to plant cells or tissues. Reporter gene activity, such as p-glucuronidase activity, luciferase activity or GFP fluorescence is monitored after transformation over time, for example 2 hours, 5 hours, 8 hours, 16 hours, 24 hours, 36 hours, 48 hours and 72 hours after DNA delivery using methods well known in the art. Reporter gene activity may be monitored by enzymatic activity, by staining cells or tissue with substrate for the enzyme encoded by the reporter gene or by direct visualization under an appropriate wavelength of light. Full-length promoter sequences, deletions and mutations of the promoter sequence may be assayed and their expression levels compared. Additionally, RNA levels may be measured using methods well known in the art such as Northern blotting, competitive reverse transcriptase PCR and RNAse protection assays. These assays measure the level of expression of a promoter by measuring the 'steady state' concentration of a standard transcribed reporter mRNA. This measurement is indirect since the concentration of the reporter mRNA is dependent not only on its synthesis rate, but also on the rate with which the mRNA is degraded.
Therefore the steady state level is the product of synthesis rates and degradation rates.
The rate of degradation can however be considered to proceed at a fixed rate when the transcribed sequences are identical, and thus this valuc can serve as a measure of synthesis rates.
[01141 Further confirmation of promoter activity is obtained by stable transformation of the promoter in an expression cassette comprising a visible marker or gene of interest into a plant as described above. Using the various methods described above such as WO 03/040322 PCT/US02/35374 enzymatic activity assays, RNA analysis and protein assays as described supra, promoter Sactivity is monitored over development, and additionally by monitoring expression in Sdifferent tissues in the primary transformants and through subsequent generations of transgenic plants.
EXAMPLES
O [0115] The invention will be further described by reference to the following detailed Sexamples. These examples are provided for purposes of illustration only, and are not intended to be limiting unless otherwise specified. Standard recombinant DNA and molecular cloning techniques used here are well known in the art and are described by Ausubel Current Protocols in Molecular Biology, John Wiley and Sons, Inc. (1994); J. Sambrook, et al., Molecular Cloning: A Laboratory Manual, 3d Ed., Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press (2001); and by T.J. Silhavy, M.L.
Berman, and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984).
Example 1: Construction of maize root forward and reverse subtracted cDNA libraries.
[01161 As a first step towards the identification of maize root-specific cDNA clones, subtracted cDNA libraries were constructed using Clontech's PCR-Select cDNA Subtraction Kit (Clontech Cat. No. K1804-1). Two different subtracted cDNA libraries were constructed; 1) a forward-subtracted library enriched for differentially expressed transcripts that are specific to the root, and 2) a reverse-subtracted library enriched for differentially expressed transcripts that are specific to all abovoground tissuoH oxcluhiVO of roots. Total RNA was isolated from maize line CG00526 including tassel, silks, seed, stem, leaf, and roots using tissue samples pooled from mature and several developmental stages for each organ. For the root, crown roots, primary roots and lateral roots were sampled from approximately five evenly divided developmental stages starting two weeks post germination and ending at maturity. Poly A mRNA was isolated from each of the total RNA props using procedures outlined in the PolyATtract mRNA isolation Systems kit (Promega Cat. No. Z3790). cDNAs were synthesized from polyA mRNA from each WO 03/040322 PCT/US02/35374 r- organ, digested with Rsa I, ligated to adaptors, and divided into "tester cDNA", and S"driver.cDNA" populations. For the forward-subtracted library the "tester cDNA" was represented by the root cDNA and the "driver cDNA" was composed of equal quantities of tassel, silk, seed, stem, and leaf cDNAs. For the reverse-subtracted library the "tester" Sand "driver" cDNA populations were the reverse of those used in the forward-subtracted library.
S [01171 The cDNA subtraction and PCR amplification for each of the libraries was 0 carried out as described in the user's manual of the Clontech PCR-Select cDNA Subtraction Kit. The PCR products of the root-specific forward-subtracted library were cloned into both the TA-cloning vector pCR2.1 (Invitrogen Cat. No. K20000-01) and into SpBSK' (Stratagene Cat. No. 212206). cDNAs ligated into pBSK- were transformed into E. coli strain DH10B cells (Life Technologies Cat. No.18290-015) by electroporation.
Transformation reactions were plated onto Q-trays (Genetix) containing media enabling blue/white colony selection. White colonies on Q-trays were robotically picked (Q-bot) into 384-well plates containing antibiotic selection media and cryoprotectant. Colonies in 384-well plates were grown up and frozen-off at -800 C. Approximately 16,000 colonies were picked. Each of the approximately 16,000 gridded bacterial colonies representing the maize root subtracted library was robotically arrayed as duplicate spots on replicate 23 cm 2 nylon membranes using a Q-bot (Genetix Limited). Colonics were grown up on membranes overlaid onto selective agar trays and subsequent in situ bacterial colony lysis and processing of membrane for hybridization were performed according to Nizetic et al.
(Nucleic Acids Res. 19(1): 182, (1991)).
Example 2: Screening of maize root subtracted cDNA library, sequencing of clones and confirmation of root specificity by northern blot analysis.
[0118] Differential hybridization screening of the arrayed library with 3 2 P-labeled probes were performed in order to identify clones whose expression was specific to the root. This was accomplished by hybridizing one of the two replicate arrays of the library with a forward-subtracted probe made from the same subtracted cDNA that was used to construct the forward-subtracted library; and hybridizing the second replica array with a reverse-subtracted probe using the same subtracted cDNA used to construct the reversesubtracted library. Probe production and hybridizations were performed according to the WO 03/040322 PCT/US02/35374 users manual of the PCR-Select Differential Screening Kit (Clontech Cat. No. K1808-1, Nylon membranes were exposed to both film (Kodak Biomax) and phosphoimager screens and densitometry values were assigned to each of the spots.
S[0119] Using visual inspection of autoradiographs and densitometry data, 300 clones n were picked for sequencing. Clones were picked on their ability to satisfy three criteria; 1) No hybridization to the reverse-subtracted probe, 2) Strong hybridization to the forward-subtracted probe, and 3) Consistent hybridization intensity between duplicate 00 spots on the same filter. The 300 sequences were arrangedinto 70 unique contigs using the Phred/Phrap program (Codon Code Corp.) for sequence analysis and contig assembly.
C
Sequence identities were searched using the Blast program and clones giving the same Sblast ID were eliminated. The resulting 36 unique clones were then evaluated for rootc specific expression by northern blot analysis.
[0120] Gel blots containing 18 ptg of total RNA (isolated from tissues at several developmental stages for each sample) from each of six different organs, tassel, silk, seed, leaf, stem, and root were hybridized with 32 P-labeled probes made from each of the 36 cDNAs. These analyses confirmed that 15 clones (2A12, 10B21, 4J8, 16M14, 29D21, 7B21, 14H6, 2D14, 16H17, 36E7, 4H19, 2P9, 6G15, 22P8, and SM13) had root-specific expression.
[01211 The 15 cDNA clones from above were then subjected to reverse northern blot analysis to evaluate whether any of the previously observed root-specific expression might be due to expression that is confined to or predominant in the root tip. Five duplicate gel blots of the 15 root-specific cDNA clones were prepared and each was hybridized with a first- strand "P-labeled cDNA probe prepared from polyA RNA isolated from either whole roots, root-tips, roots without tips, crown root tips, or crown roots without tips. The intensity of the 32 P-labeled band on the autoradiograph was characterized as high medium low or absent The results shown in Table 1 indicate that expression of all 15 clones was not confined to the root tip and that substantial expression was found throughout the root.
WO 03/040322 Table 1. Results of Northern and Reverse Northern Analysis.
PCT/US02135374 Relative Relative Levels of mRNA In Reverse Northern Levels of Crown mRNA in Whole Roots w/o Crown roots w/o Clone Northern roots Rottips root tips root tips root tips 2A12 2D14 -H 2P9 41119 -HH- -i-H i 4J8 6G15 7B12 4+-H 10B21 14H6 16H17 -i-H H i 16MI4 4+ 22P8 291321 36137 SM13 44H+ Example 3: Obtaining full-length cDNA clones for selected root-specific cDNAs.
10122] Using the above northern and reverse northern expression data, four clones, 22P8, 10B21, 2D14, 4H19 were chosen to obtain full-length cDNAs. All four of the original eDNAs for these clones represent 3' fragments each containing poly A tails. 5' RACE PCR using Clontech's Marathon eDNA Amplification Kit (Cat. No. Ki 802- 1) was used to extend the partial eDNA clones. Because of the high G+C content of maize DNA, incremental RACE extensions utilizing the following RACE gene-specific primers (SEQ ID NOS: 13-26) and the adapter primer (SEQ ID NO: 27) were used to obtain the fulllength cDNA products: Gene specific primers used for each designated clone Clone Primer Seauence 22P8 5 '-CACACTAGCGCACAGAGATCAGAG-3' '-GCACCAACACAAGCACAACAGAAC-3' '-CAGGGTACATCTflGCCGCACTTGC-3' SEQ ID NO (SEQ ID NO: 13) (SEQ ID NO, 14) (SEQ ID NO: I~ WO 03/040322 1O0B21 3 5'-CATGC] CGCGGCTAGCTTAGAGG- 3 3 )-TGAGGCrGAGGTCGACGGCAGG- 3
'-CGAGGTCGACGAGTCCCTCAGC-
3 5'-TTAGCACCGGCGTAGAAGTGATCG- 3 tGCATGGAATGGAAGGGAGGCAGC- 3 5 )-ATACAACGCAAGGTCGCTCACTG- 3
'-CATGACCGCTAAGGATCAGGAGAC-
3 5'-TCT-CGTGCACCGCCGAGC-3' 5'-TGCACTCACACCGCCGATGATGG-3' PCTIUSO2/35374 /SQI O 6 (SEQ ID NO: 17) (SEQ ID NO: 17) (SEQ ID NO: 18) (SEQ ID NO: (SEQ ID NO: (SEQ ID NO: 21) (SEQ ID NO: 22) (SEQ ID NO: 23) (SEQ ID NO: 24) (SEQ ID NO: 21314 4H1 9 Adaptor 5'-CCATCCTAATACGACTCACTATAGGGC- 3 (SEQ ID NO: 27) 101231 The results of the RACE extensions of the cDNA clones and the primers utilized for this process are shown in Table 2. A full-length cDNA candidate (SEQ ID Nos: 5, 7, 9, and 11) was obtained for each of the four clones. Thc full-length or near full-length, cDNA clone obtained by RACE PCR allowed for the prediction of the translation initiating ATG for each of tht: cDNA clones.
Table 2. Results of cDNA RACE Extension.
cI)NA ~Izu Original cDNA size (bp) 345 Predicted size of full-length cDNA (bp) 650-700 Clone 22P8 5' RACE primer name SEFQ ID NO: 13 SEQ 1ID NO: 14 obtained by RACE (bp) 700 cDNA obtainedI by RACE SEQ ID SEQ1D NO: SEQ ID NO- 16 WO 03/040322 PCT/US02/35374 16B21 406 700-800 SEQ ID NO: 17 766 SEQ ID NO:7 SEQ ID NO: 18 SEQ ID NO:;19 SEQ ID 2D14 306 700-800 SEQ ID NO:21 730 SEQ ID NO:9 SEQ ID NO:22 4H19 311 700-850 SEQ ID NO:23 660 SEQ ID NO:I I SEQ ID NO:24 SEQ ID SEQ MD NO:26 Example 4: Isolation of promoter/genomic clones corresponding to the root-specific cDNAs.
101241 Promoter/genomic clones corresponding to cDNAs 22P8, 10OB21, 2D 14, 4H1 9 (SEQ ID NOS: 5, 7, 9, and 11, respectively) were isolated via PCR utilizing either maize "Genome Walker" or X EMBL3 genomic librarics as tcmplate. "Gcnorne wulkcr" adaptor-ligated maize genomic libraries were constructed using DNA from maize line CGC000526 and Clontech's Universal Genome Walker kit (Clontech Cat. No. K1807-1).
Five different libraries were constructed, each comprised of genomic DNA fragments generated by digestion with one of the following blunt end restriction enzymes: DraI, EcoRV, HincJJ, SspI, or SMu. Genome Walker libraries were screened utilizing the following geno-spoci flc primecra (SEQ I D NOS: 28-34) and thoa Ldapter pri mur (SI13Q I NO: 35) which was supplied in the kit: Gene specific primers used for each designated clone Clone Primer Seuence 22P8 5 '-TCCTCGAGCTCIMCG'TTGCTTTGGAAAC-3' 1 0B21 15'-ACACCACCAGGTTCACGGCGAGGAACAG-3' -GAGGCCTTGCCTGCCATTGCTGCAGAGT-3' SEQ ID NO, (SEQ ID NO: 28) (SEQ ID NO: 29) (SEQ ID NO: 39) WO 03/040322 PCTFUS02/35374 2D14 5'-AGCAGTTGGACGTGCAGGCGTTGGCTAC- 3 (SEQ ID NO: 31) 3 (SEQ ID NO: 32) n 4H19 5'-TCTTTCTTGTGCACCGCCGAAGC-3' (SEQ ID NO: 3.3) 5'-TGCACTCACACCGCCGATGATGG-3' (SEQ ID NO: 34) o0 Adaptor 5'-GTAATACGACTCACTATAGGGC-3' (SEQ ID NO: S [0125]. PCR conditions were those suggested in the Clontech users manual. PCR reactions were fractionated on agarose gels, and the resulting product band was excised, cloned in a Topo vector and sequenced to verify the correct product. Promoter clones corresponding to cDNAs 22P8, 10B21, 2D14, 4H19 (SEQ ID NOS: 5, 7, 9, and 11, respectively) were cloned from these libraries.
[0126] The X EMBL3 library was custom made by Clontech (Clontech Cat. No. csl012j) using genomic DNA from maize line CG000526. The 1.4 kb promoter clone corresponding to cDNA 22P8 (SEQ ID NO: 5) was cloned from this library. The library was PCR screened using 22P8GSP7, 5'-ACTATAGGGCACGCGTGGT-3' (SEQ ID NO: 36) in conjunction with the following 5' and 3' X arm primers supplied by Clontech (Cat. No.
9104-1): 5'-CTGCTTCTCATAGAGTCTTGCAGACAAACTGCGCAAC-3' (SEQ ID NO: 37) 5'-TGAACACTCGTCCGAGAATAACGAGTGGATCTGGGTC-3' (SEQ ID NO: 38) PCR was done using conditions suggested in the user manual supplied with the primers.
The 22P8 promoter clone was a product of the 3' X primer and 22P8GSP7 primer.
Example 5: Construction of Root-specific Expression Cassettes Entry Vectors [0127] The first step in construction of expression cassettes was the cloning of the promoters into an entry vector. PCR primers were designed to amplify each promoter WO 03/040322 PCT/US02/35374 and to place attBlI and attB2 sites on the 5' and 3' ends, respectively. The promoter corresponding to the cDNA 22P8 was designated as Maize Root-Specific 1 or MRS 1.
Two different promoter constructs were made from MRS 1; the full-length MRS I ;Z comprising nucleotides 1 to 1391 of SEQ ID NO: 1, designated NMSL, and a second.
V) shorter fragment of MRS1 comprising nucleotides 601 to 1391 of SEQ ID NO: 1, designated MRS 1S. MRS1L was PCR amplified out of Genome Walker library EcoRV with primers 22P8DS 1 5'-TTAA GAACATGACGGATGAAGAATCACT- 3 (SEQ ID 00 NO: 39) and 22P8GSP6 5'-TGATCCGCAGTI'GCAGC'IFIGATCC-3' (SEQ ID NO: followed by 22P8DS1 (SEQ ID NO: 39) and the nested primer 22P8GSP7 (SEQ ID NO: 36). Att sites were added to MRS1L by PCR amplifying the product of the nested reaction with primers consisting of V2 att and /2 gene-specific sequence, 22P8D55
ACAAAAAAGCAGGCTGAACATGACGGATGA-
3 (SEQ ID NO: 41) and 22P8DS9 3 '(SEQ ID NO: 42). The full attB I and attB2 sites were added by using primer atBi GGGGACAAGT'flGTACAAAAAAGCAGGCT-3'(SEQ ID NO: 43) and attB2 GGGGACCACTT11GTACAAGAAAGCTGGGT- 3 (SEQ JD NO: 44). MRS1S (nucleotides 601-1391 of SEQ ID NO: 1) was PCR amplified out of Genome Walker library EcoRV with primers 22P8D5 1 (SEQ ID NO: 39) and 22P8GSP6 (SEQ ID NO: followed by the nested primers 22P8DS3 GCGTAGTI7GAAGCTACAAAGTTGCAT-3' (SEQ ID NO; 45) and 22P8G5P7 (SEQ ED NO: 36). Aft sites were added to MRS iS by PCR amplifying the product of the nested reaction-with primers consisting of 1/2 att and gene-specific sequence, 22P8DS7
ACAAAAAAGCAGGCTGTAGTGAAGCTTAC-
3 (SEQ ID NO- 46) and 22P8DS9 (SEQ ID NO: 42). The full attBl and attB2 sites were added by using primers attB 1 (SEQ ID NO: 43) and attB2 (SEQ ID NO: 44).
101281 ,The promoter corresponding to the cDNA I10B21 was desigrnited Lis M1621, (.SIQ ID NO: MRS2L was amplified out of Genome Walker library EcoRV by PCR amplification with primers 1 0B2 1DS 1, 5 'GACGGCCCGGGCTGGTAAATIGACTT-3' (SEQ ID NO: 47) and 1OB2IGSPI, 5'-CATGCTCGCGGCTAGCTTrAGAGG-3'(SLEQ ID NO: 48) followed by the nested primers 10OB2 1 D3, TGQTAAATTGACTTTGCCTAGTGTTGGA-3' (SEQ ID NO: 49) and 1 OB21 GSP2, 5'-ACAGTCTTGCCGCAGTGGTTGAG-3' (SEQ ID NO: 50). Att sites wora ad~dc(I to MRS2 by PCR amplifying the product of the nested reaction with primers consisting of Y2z WO 013/040322 PCT/US02/35374 att and Y/2 gene-specific sequence, 1OB21DS5, 0 ACAAAAAAGCAGGCTTGACTTTGCCTAGTG- 3 (SEQ ID NO: 5 1) and IlOB2lIDS7, 51-ACAAGAJAGCTGGGTTGCTGCAGAGTACAG- 3 (SEQ ID NO: 52). Thc Cuill attBl1 and attB2 sites were added by using primers attBl1 (SEQ ID NO: 43) and attB2 (SEQ ED NO: 44). Two shorter fragments of MRS2L were made. One fragment of MRS2L comprising nucleotides 921 to 2869 of SEQ ID NO: 2, designatcd MRS2M, and (N a second fragment of MRS2L comprising nucleotides 1913 to 2869 of SEQ ID NO: 2, 00 designated NM2S. Fragments of the MRS2L promoter were generated with PCR using the MRS2L promoter (SEQ ID NO: 2) as template and gene specific primers (SEQ ID r_ NOS: 64-67). The sequence CACC was added to the 5' end of each forward primer to allow directional cloning into the pENTR-D/TOPO plasmid (Invitrogen). This directional cloning produced an entry vector comprising either the MRS2M fragment or the MRS2S fragment. MRS2-specific primers used to make the MRS2 promoter fragments were as follows: Primer Primer Sequence SEQ ID NO MIRS2 Rev 5'-GCTGCAGAGTACAGAAAGCA-3' SEQ ID NO: 64 MRS2L Fwd 5'-CACCGGCTTGAC'fTTGCCTAGTGT-3' SEQ ID NO: MRS2M Fwd 5'-CACCTGCGCGTGTTCGTAGAGTTG-3' 'SEQ ID NO: 66 MRS2S Fwd 5'-CACCTGAACTTGTGCA*CGTCATTT-3' SEQ ID NO: 67 Combinations of PCR primers used to generate the MRS2 promoter fragments were as follows: Primer Pair Product ISize -ILocation on SEQ ID NO: 2 MRS2M Fwd MRS2 Rev MRS2M 1949 921 to 2869 MvRS2S Fwd +MRS2 Rev MRS2S 957 I1913 to 2869 101291 The promoter corresponding to tho cDNA 2D14 wits dosignatcd its MRS3 (SIIQ ID NO: MIRS3 was amplified out of Genome Walker library EcoRV by PCR with primers 2D14DSl, 5'-ATGGGT'1TGCGGGTATGGGTAGTGGTA-3' (SEQ ID NO: 53) and 2D1I4GSP5, 5'-ACACCACCAGGTTCACGGCGAGGAACAG-3' (SEQ ID NO: 54). Att sites were added to MRS3 by PCR amplifying the product of the primary reaction with primers consisting of Y2 ati and Y2~ gene-speci fic sequence, 2D1I4DS3,
ACAAAAAAGCAGGCTGCGGGTATGGGTAG-
3 (SEQ ID NO: 55) and 2D14DS5, 3 (SEQ ID NO: 56). The full WO 03/040322 PCT/US02/35374 attB1 and attB2 sites were added by using primers attB1 (SEQ ID 43) and attB2 (SEQ ID 1N NO: 44).
10130] The promoter corresponding to the cDNA 4H19 was designated as MRS4 (SEQ ID NO: MRS4 was amplified out of Genome Walker library DraI with primers S4H19GSP3, 5'-TCTTTCTTGTGCACCGCCGAAGC- 3 (SEQ ID NO: 57) and 4H19profor, 5'-ACCCGATAACGAGTTAACGATATGAACTGG-3' (SEQ ID NO: 58) followed by amplification with nested primers 4H19GSP4,
TGCACTCACACCGCCGATGATGG-
3 (SEQ ID NO: 59) and 4H19profor (SEQ ID i NO: 58). Att sites were added to MRS4 by PCR amplifying the product of the primary reaction with primers consisting of Va att and gene-specific sequence, 4H19proforB1, ,I 5'-ACAAAAAAGCAGGCTAACGATATGAACTGG- 3 (SEQ ID NO: 60) and 4H19 prorevB2, 5'-ACAAGAAAGCTGGGTCTTCACGAGTTCGGT-3' (SEQ ID NO: 61).
Each promoter with attB1 and attB2 ends was recombined into plasmid pDONR 201(Life Technologies Cat. No. 11798-014), a donor vector with attP recombination sites, using the BP clonase mix of recombination enzymes (Life Technologies Cat. No. 11789-013).
In this entry vector each promoter was directionally cloned with the 5' end of the promoter adjacent to the attL1 site and the 3' end adjacent to the attL2 site. A separate entry vector was made for each of the four promoters.
Destination Vectors [0131] A Binary destination vector, useful for plant transformation, was constructed in the following manner. A recombination fragment (rf) containing lambda bacteriophage attachment-R (attR) sites flanking a chloramphenicol resistance gene and a controlled cell death (ccd) gene was obtained from Invitrogen (Cat. No. 11828-019). Oligonucleotides were obtained to amplify the rf cassette by PCR, incorporating a flunking 5' Bell sito, rfBclI, 5'-TGCCCGTATGATCAACAAGTTTGTACAAAA-3' (SEQ ID NO: 62) and a 3' EcoRV site, rfEcoRV, 5'-CCAGACCGATATCAACCACTTTGTACAAGA- 3
(SEQ
ID NO: 63) into the cassette. The addition of these unique restriction sites made it possible to directionally subclone the recombination fragment in front of the pglucouronidase (GUS) gene and nopaline synthase (nos) terminator (rf::gus::nos) to produce an intermediate donor vector. The expression cassette (rf::gus::nos) was removed from the donor vector by endonuclease digestion using Kpnl and gel purification WO 03/040322 PCT/US02/35374 of the -3 kb fragment. A recipient binary vector (Negrotto et al., 2000 Plant Cell Reports 19: 798-803) was prepared for ligation of the expression cassette by endonuclease digestion using KpnI and dephosphorelated using calf intestine phosphatase C, (CIP). The expression cassette was then subcloned into the KpnI site within the T-DNA Sregion, near the right border of a binary plasmid. The T-DNA region of the final binary destination vector harbored the recombination expression cassette followed by a plant 1 selectable marker expression cassette comprising the maize Ubiquitin promoter driving 00 the phosphomannose isomerase gene and nos terminator (Negrotto et al., 2000 Plant Cell Reports 19: 798-803). The root-specific promoters, MRS1L, MRS1S, MRS2L, MRS2M, MRS2S, and MRS3, were each cloned into the final binary recombination vector in front Sof the GUS coding sequence. Thus, six binary vectors were made, MRS1L-GUS, MRS S-GUS, MRS2L-GUS, MRS2M-GUS, MRS2S-GUS, and MRS3-GUS.
Example 6: Transient Expression in Maize directed by root-specific promoters [0132] Maize seeds were germinated and grown in the dark under sterile conditions for seven days. Root tissue was cut into 1 cm segments with sterile razor blades and arranged onto agarose plates prepared with 2JMS+AG media (JMS majors, SH minors, MS iron, 2% sucrose, 5mg/ml dicamba, G5 additions, 10mg/ml AgNO 3 Five micrograms of DNA from vectors comprising MRSIL-GUS, MRS S-GUS, MRS2L-GUS, und MRS3-GUS was precipitated onto (<lpm) gold carriers and spotted onto micro-carriers for bombardment at 650 psi as described (Wright et al. 2001, Plant Cell Reports, 20: 429- 436). Fragment DNA was precipitatcd onto gold mlirocnrriers mIm) uIs dcuNribedl ill th DuPont Biolistics Manual. Genes were delivered to the target tissue cells using the PDS- 1000He Biolistics device. The approximate settings on the device were as follows: 8mm between the rupture disk and the macrocarrier, 10mm between the mncrocarricr nd the stopping screen and 7cm between the stopping screen and the target. The plates were shot twice with DNA-coated particles using 650 psi-rupture disks. To reduce tissue damage from the shock wave of the helium blast, a stainless steel mesh, with 200 openings per lineal inch horizontally and vertically (McMaster-Carr, New Brunswick, NJ), was placed between the stopping screen and the target tissue. Roots were cultivated on the plates for 48 hrs in the dark at 25 0 C. Expression of GUS was visualized by staining with 100mM NaPO 4 0.5 mM Potassium Ferricyanldo, 0.5 mM Potassium
II.
WO 03/040322 PCT/US02/35374 Ferrocyanide, 10mM EDTA pH 8.0, 0.5 mg/ml X-Gluc, 0.1% Triton X-100. Table 3 S shows the relative levels of GUS expression of the root-specific promoter constructs Scompared to a construct with the constitutive maize ubiquitin promoter driving expression S ofGUS, UbiP-GUS. A wildtype (Wt) maize plant was used as the negative control. GUS activity is characterized as high medium low or absent Results indicate that promoters of the invention function in plant cells and drive the expression of Sa heterologous coding sequence at comparable levels to a constitutive promoter.
00 C Table 3. Results of Transient Expression of GUS in Maize Roots.
Construct Relative GUS Expression Levels Wt UbiP-GUS MRS1L-GUS MRS1S-GUS MRS2L-GUS MRS3-GUS Example 7: Expression of GUS in Stably-transformed Corn and Rice Directed by Rootspecific Promoters [0133] Maize and rice plants were transformed with expression cassettes comprising promoters of the invention operably linked to the GUS coding sequence. GUS activity in stably transformed maize and rice tissues was measured by a fluorometric assay. Plant tissue was ground in extraction buffer (50mM Nn 2 H-PO4 pH 7.0, 5mM DTT, 1 mM NA 2 EDTA, 0.1% Sarcosyl, 0.1% Triton-X). The reaction was carried out with approximately one part tissue extract to 5 parts assay buffer (extraction buffer with 47mM 4methylumbelliferyl-glucuromide) at 37 0 C and stopped with 2% Na 2
CO
3 at multiple time points. The activity was measured in a Tecan Spectrafluor Plus at 365nm excitation and 455nm emission calibrated with 4-MU standards diluted in Na 2 Co 3 The slope of MU fluorescence verses time gives the activity of the GUS enzyme. Protein concentrations were measured by BCA assay (Pierco Cat. Nos. 23223 and 23224) uld Gun activity waN WO 03/040322 PCT/US02/35374 normalized for protein concentration. Gus activity was characterized as high medium low absent and data from 12 to 31 single copy transgenic maize plants or 7 single copy transgenic rice plants were averaged for each promoter construct.
Results shown in Tables 4 and 5 demonstrate that GUS activity in transgenic plants comprising an expression cassette that comprises a promoter of the invention was confined specifically to the roots.
Table 4. GUS Expression in Tissues Excised from Transgenic Maize Plants.
Promoter _GUS Activity in Designated Maize Tissue Root Leaf Silk Pollen Kernel UbiP MRS1L MRSIS MRS2L MRS3 Table 5. GUS Expression in Tissues Excised from Transgenic Rice Plants.
Promoter GUS Activity in Desi mated Rice Tissue Root Leaf Wildtype UbiP MRS2L MRS2M MRS2S Example 8. Expression of Insecticidal Toxin Using Root-Specific Promoter [0134] Maize plants were transformed with an expression cassette comprising the MRS3 promoter operatively linked to a heterologous coding sequence that encodes i modified Cry3A toxin Application No. 60/316,421). Excised roots of transformed plants expressing the insecticidal toxin were bioassayed against western corn rootworm and were observed to be insecticidal. Transformed plants comprising the MRS3-modificd Cry3A expression cassette were resistant to com rootworm larval feeding damage.
[0135] It will be recognized by those skilled in the art that the promoters of the present invention can be operably linked to other heterologous coding sequences that encode toxins active against corn rootworm, for example, the PS149B1 proteins (Moellenbeck et WO 03/040322 PCT/US02/35374 al. 2001, Nature Biotechnology 19: 668-672), a modified Cry3Bb toxin Patent No.
6,063,597), the Diabrotica toxins disclosed in U.S. Patent No. 6,281,413, or the Vipl- SVip2 toxin Patent No. 5,872,212).
[0136] All publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same 0 0 extent as if each individual publication or patent application was specifically and O individually indicated to be incorporated by reference.
[01371 Although the foregoing invention has been described in some detail by way of 0illustration and example for purposes of clarity of understanding, it will be obvious to persons skilled in the art that certain changes and modifications may be practiced within the scope of the present invention.

权利要求:
Claims (26)
[1] 1. An isolated nucleic acid molecule which codes for a promoter capable of directing S root-specific transcription in a plant, wherein the nucleotide sequence of said promoter comprises a nucleotide sequence selected from the group consisting of: a. a nucleotide sequence of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, or N SEQ ID NO: 4; b. a nucleotide sequence that hybridizes under high stringency conditions to a O nucleotide sequence of and c. a nucleotide sequence comprising a fragment of a sequence of wherein said fragment maintains function of the nucleotide sequence of a).
[2] 2. The isolated nucleic acid molecule according to claim 1, wherein said promoter comprises the nucleotide sequence set forth in SEQ ID NO: 1.
[3] 3. The isolated nucleic acid molecule according to claim 1, wherein said fragment comprises nucleotide numbers 603-1392 of SEQ ID NO: 1.
[4] 4. The isolated nucleic acid molecule according to claim 1, wherein said promoter comprises the nucleotide sequence set forth in SEQ ID NO: 2. The isolated nucleic acid molecule according to claim 1, wherein said fragment comprises nucleotide numbers 921-2869 of SEQ ID NO: 2.
[5] 6. The isolated nucleic acid molecule according to claim 1, wherein said fragment comprises nucleotide numbers 1913-2869 of SEQ ID NO: 2.
[6] 7. The isolated nucleic acid molecule according to claim 1, wherein said promoter comprises.the nucleotide sequence set forth in SEQ ID NO: 3.
[7] 8. The isolated nucleic acid molecule according to claim 1, wherein said promoter comprises the nucleotide sequence set forth in SEQ ID NO: 4. 'I WO 03/040322 PCT/US02/35374
[8] 9. The isolated nucleic acid molecule according to claim 1, wherein said nucleic acid molecule is isolated from the root tissue of a target plant species. n 10. The isolated nucleic acid molecule according to claim 9, wherein said target plant species is maize. C. 11. An expression cassette comprising, in sequence, the nucleic acid molecule of claim 1 00 operably linked to a heterologous coding sequence, which is operably linked to a 3'- O untranslated region including a polyadenylation signal.
[9] 12. The expression cassette according to claim 11, wherein said heterologous coding sequence is selected from the group consisting of insecticidal coding sequences, nematicidal coding sequences, herbicide tolerance coding sequences, anti-microbial coding sequences, anti-fungal coding sequences, anti-viral coding sequences, abiotic stress tolerance coding sequences, nutritional quality coding sequences, visible marker coding sequences and selectable marker coding sequences.
[10] 13. The expression cassette according to claim 12, wherein said insecticidal coding sequence encodes a toxin active against a colcopteran pest.
[11] 14. The expression cassette according to claim 13, wherein said coleopteran pest is a species in the genus Diabrotica. The expression cassette according to claim 12, wherein said visible marker is 1- glucuronidase.
[12] 16. A recombinant vector comprising the expression cassette of claim 11.
[13] 17. The recombinant vector according to claim 16, wherein said vector is a pina it.
[14] 18. A transgenic non-human host cell comprising the expression cassette of claim 11.
[15] 19. The transgenic host cell according to claim 18, which is a plant cell. WO 03/040322 PCT/US02/35374 2 20. A transgenic plant comprising the transgenic plant cell of claim 19. S 21. The transgenic plant according to claim 20, wherein said plant is selected from the. group consisting of sorghum, wheat, sunflower, tomato, cole crops, cotton, rice, soybean, sugar beet, sugarcane, tobacco, barley, oilseed rape and maize. 00 22. The transgenic plant according to claim 21, wherein said plant is a rice plant.
[16] 23. The transgenic plant according to claim 21, wherein said plant is a maize plant.
[17] 24. Transgenic seed from the transgenic plant of claim 21. Transgenic seed from the rice plant of claim 22.
[18] 26. Transgenic seed from the maize plant of claim 23.
[19] 27. A method of specifically expressing a heterologous coding sequence in transgenic plant roots comprising: transforming plant cells with a vector, wherein said vector comprises the expression cassette of claim 11, growing the transgenic plant cells comprising said expression cassette, and producing transgenic plants from said transformed plant cells wherein the heterologous coding sequence is specifically expressed in plant roots under control of said nucleic acid molecule.
[20] 28. The method according to claim 27, wherein the transgenic plant roots are maize or rice roots.
[21] 29. The method according to claim 27, wherein said heterologous coding sequence is selected from the group consisting of insecticidal coding sequences, nematicidal coding sequences, herbicide tolerance coding sequences, anti-microbial coding scqucnces, anti- fungal coding sequences, anti-viral coding sequences, abiotic stress tolerance coding WO 03/040322 PCT/US02/35374 sequences, nutritional quality coding sequences, visible marker coding sequences and O selectable marker coding sequences.
[22] 30. Transgenic plants produced according to the method of claim 27.
[23] 31. The transgenic plants according to claim 30, wherein said plants are maize or rice CI plants. 0 0O
[24] 32. A method of isolating a promoter capable of directing root-specific expression in plants comprising: preparing a nucleic acid probe from any one of SEQ ID NOS: 1-4; hybridizing said nucleic acid probe to either cDNA or genomic DNA prepared from a plant; and isolating a hybridizing sequence from said cDNA or said genomic DNA with at least 70% identity to said nucleic acid probe.
[25] 33. A method of identifying fragments of a promoter capable of directing root-specific expression in plants comprising: providing the isolated nucleic acid molecule according to claim 1; generating fragments of a promoter sequence comprised in the nucleic acid molecule of step S(c) transforming plants with the fragments of step operably linked to a heterologous coding sequence; and identifying the fragments of step having promoter activity in a transgenic plant by expression of the heterologous coding sequence in a root-specific manner.
[26] 34. A primer comprising at least 16 contiguous nucleotides of a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NO: 4. WO (03/040322 PCTIUS02/35374 A hybridization probe comprising at least 50 contiguous nucleotides of a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ BD NO: 3, and SEQ IDNO: 4. ;Z 00 WO 03/040322 WO 03/40322PCT/US02/35374 SEQUENCE LISTING <110> Syngenta Participations AG <120> Promoters for Regulation of Gene Expression in Plant Roots <130> 60115 <150> <151> US 60/337,026 2 001-07-11 <160> 67 <170> Patentin version <2 10> <211> <212> <213> <220> <221> <222> <223> <220> <221> <222> <223> <220> <221> <222> 1 1392 DNA Zea mays promoter (1392) MRS1L promoter (603). .(1392) MRS1S cAAT.s1gnal (1251).. (1254) WO 03/040322 WO (3104322PCT[US02/35374 <220> <221-> TATA-.signal <222> (1288)...(1295) <400> 1 gaacatgacg ctgtcctaaa tgttttatat ggctaaaacg ccatgatggg agatctagtt ctgctagtga tcagtcggta cgctttgaga aaaaggtact gcgtagttga ggataacgtt cgcgccctgg gcaagaaatt agtatgtgtg tttgacgcgc aaaataiaac agcagaggaa gtacttgtta aacatttgtc tgtaataaac cggtgacctt accaatccat aagagctcga gatgaagaat ttaatatttg atatgtctag actactattt ctagtgattt aactgctgtt ttctgttaac gagcgcaagg tgtttatttt acaggtgttt agcttacaaa ttaaactggc acggcgtgta ccaaatatat gcggaggaaa gcgggtagaa tatagtctat gacaagcaga attactggca taggttccgc gaaactagga gatgcaccac aactcgaaac gg cactattgtt tttaaacttt atttataatt tgaaacggaa aatttacata actgaatagc aaataatgtt ctcttaacct ttgttgactt taaactggca gttgcatact aacaatatct aagagccagc tttattaatc tcttgaggac gttgcagaag agtgtgtcaa gcacgcctta cgcattatca acgtataatt acgaaagcaa cgcgtgctat cttttcttgt ttcttctttg ttattggatt attcatatga ggagtagtaa tatattggtg gaagacaaat tattgtgatt tgtggtcgtg ttgcttggtt acctttggag tgcatatgag tgctgtttca atcggcat ca caaaagaagg gaacgtatca acagtgggta atgtcaa caa ttagcttgct acaatgcagt ccgccgcgcg aaaaaccag-t gctctgtCtg cgtagaagat catgtaataa atatggacat tttatttaag ttttgggctc atataattta ttaacaacag ggttcgagcc gcgtgggatt cgtcgaggCg atgattgccg aattcaggcg ttgtcaaacg cacaaattag aaggaggcac cggtcttatc gaggaagggc tatttgtatc tctggatgtg ttttttgggg catgtttttg gtccccgagt tgtgtttcca aatactcctc ttaatgt atg aaaaatctag cggaggggaa ttacatgaga agctccccaa cccgtctagc ccacggtggg tccgagaaaa acgtgcattt gacatgaagc tgggaagcta atcgacaagg tttggttttt aagataatag ctaataaaat cagccaaatt gtggtggtgt aatctagaca gaacggaagc caatagatta ctactcat ca aagcaaacga 120 180 240 300 360 420 480 540 600 660 720 780 840 900 960 1020 1080 1140 1200 1260 1320 1380 1392 <210> 2 <211> 2869 <212> DNA <213> Zea mays WO 03/040322 WO 03/40322PCTIUS02/35374 <220> <221> <22 2> <223> <220> <221> <222> <223> <220> <221> <222> <223> <220> <221> <222> <220> <221> <222> promoter (2869) MRS2 promoter (921). (2869) MRS2-M promoter (1913). (2869) MRS 2-s CAAT..si gnal (2563). .(2566) TATA-si gnal (2745). .(2751) <400> 2 ggcttgactt tgtatttgtg agaaactctt ttttctttta gaaataaaac tctgcttgat cdgattttgt aaacataatt atgcatgata accgttagct tcggttcctg tgcctagtgt acactcggca tgtcgagtgt ccgagggttt actcggcaaa gaataaagct tatgagtcat aattgaggca catttgacgc agtccatgta tccaaaaaac tggagaaaaa aagagccctt caaaaataaa tttgtgtggc gaatatgaca tatatattgt atttcatttt acgatccata aattatccat gaaggcacta tctaccacct acactcggca tgccgagtgt acactcggca actcggcaaa ctcggcaaag tcgaaatatg catacacgtc tacatttgag aattaattga aacgtctcta ttcaatagct 3 aagagctctt caaaaaaaga aaggtcttct gagctttttg agccaaattt tgtgcatatt gtttgcaaat acgtagaatt tcggcaacgg gtggcacgcc cttttgggct tgccgagtg t cactcggtaa tcgccgagjtg ccgagtgccc cggtagtgaa gttctaatat gcactacata actagtattc c-tag ctt cC a atacatattg cgagggctat 120 180 240 300 360 420 480 540 600 660 WO 03/040322 WO 03/40322PCT/US02/35374 aaataaatag aattgagact tcgtgtaggt aggttatgcc ccattatatg tgtgagatca gtcatgaagt caaatacgga ctaggagctt agaagcttac tatctctatc tttcctaact tatagagata tgtataggtt gattcatccc ggatgaaggg ggagtgttga ttgaacattt aaatatggtt atgcttaaag taatataatt tgcacgtcat gtgcatgaag tagtattagt caaaaagggc tttgaatgtt attttagtga agtaaaatt t gcatagctct tgggcgtcca gttactagat ccatcaagcg gctgttgaaa catctaatta caccacagtg ccgatctatt gttttgcaaa tagttgagct catcgacact ca ctaaccac ttcagtcaga gcgccactta ggccctcgCg atatttcttg tcatttaagc t agttacatg gcaacactta ttgcttaaga tctcttagat gtagtgagtg ctctctgata acattcaagc gaaacgcagt gatgaagtgg tacctttctt ttatgtttct cactcggcaa acactctttt acccaccgtt ccaactgaac ttg~aattgc tgatcatttc gcgcttggat ccgtccatgc acaagcagcc agaacaagca cttggttctg ataatcgccc ggctatttct agttcttaga gtacttaagt agacaccctc tgcgcgtgtt gtttatgctg agtt cgatag tgagtggaga tgggctaccc ataccttagt ttctgcattt ctagttagta aacaaaacct gattcaatta gcccacgttc agtgacacac tctcgacaaa aattcaattc aggacgtaag gctattcgat ttggacatct tatacttgga aacagctatc tcataaacaa gtttgtgggc ataataaatg cttctgagcg attctaccat cccgtgaagt atcaccatga aacccatatg tcaacatgca gagtaccacc tcacatgcac caagttttgt catctaagtg cagttagacc aaacggtcaa cgtagagttg cggcctccac tgaagacaac aggctcgtga tttgcgtagg aaaaaatatc atattgctaa ggactgaaaa tagttgcact gaagcctaaa cttctagaga ttgcatgggt acgtcgtcat ttgttttgta aaattttatg agcattgaac tagtcttgta gcttgccaaa tccggtggtg gcggaaccat atgctt ctta ttgacccgat cattcagttt gcaagggtgc gcagaaaaat tacctctgct acaagttcct tccaccagtg caaatattag tcatgctcac 4 gctgagaaac ctttaaggtt gtcactataa acccttgatg taccaggaag cgtacactag caagagcatc ctatctgcgg ggttccgacg agcgtgtcca atttggttgt cttaggttac agctttcttg ttagcgtgaa gcacttgatc gctctaacaa gttaataatc ttactataat atataattga tattataaga ctaaactatt tgttttctgg aagagttggg ctagccaaca agcaaattca cagggacaga tacgatgagg acccgtaccc acttcaactg gatgtttagc aactgaataa g agcaatctt tggatcaaat gggaatgtaa atagcaagag actcggtgat cacttgctct cttgtgcgca ggttgtatct agcgaacgag cgagagaggc agttacctgg aggattagga catgacttta gtgctttacc ataactacat gttatatatt tagttgttct ctgcttgcac ggaccagtga cttctttact tgtcatgctg aaatttatgt agcattattt tttgaacttg gctttgtgaa gtaaatgtat gtacgtcata agcctctaac gctaaagcaa atacgtttag accg ctatat ttcaacaact actcgatcac aaatgatcaa ggccacttgc ccagatcagc actcacacaa 720 780 840 900 960 1020 1080 1140 1200 1260 1320 1380 1440 1500 1560 1620 1680 1740 1800 1860 1920 1980 2040 2100 2160 2220 2280 2340 2400 2460 2520 2580 2640 2700 WO 03/040322 WO 03/40322PCT/US02135374 caacactgct aatacactaa tcggcactgc gccgatggtt ctcctataaa tgcaacaatc aagcgccacc acgaaccatc acaagcgctt agtgatcagt taatactaag ggcaggcaca cctctgcttc gcgctagtga tcaagcaagt gctttctgta ctctgcagc 2760 2820 2869 <210> <211> <2 12> <213> <220> <221> <222> <223> <220> <221> <222> 3 973 DNA Zea mays promoter (973) MRS3 TATA..si gnal C840). C847) <400> 3 ggctgcgggt ttgaacccat caaaaaccca gaaagcactc tgaagttgat gaatgctgtt ttg ctggtat tgtgcgtaca aattgacatc gatcccaagc ccatgcatgc atatgcgata agatcggact gggttcacat ataaaatccc caagaacaag atgggtagtg taacaaactc ccgggtttCg ggcaaagagc atgcccttcg ccttaaaaaa acctgcacca tgcctatgga taatgccctc taaaataaca gcagcgatct ccgtatgagg cttcgcaacg gaacgctccc ctggtaacac agctctctac gtagaacaaa atgggtacag ggtaccgggt tggattcggg gaacgaatga acgtttcgat tgcatgcgtc tgatcacagg tgctcaactt cccaatcgtc tggccatttg gaaaacacta taaccggctt gtgcctagtt cgtgatcaaa ctgcattggC cccatgccca aaattgaccc acccattgcc tagcgcgggg ccccaaaatt gctaaacaaa cgcgctattc cacgccacat gcgcacgcta atat aaaa a c cggagccaac gttattataC cttcacatgc gcaccgattt gcatcgcaaa tagcgtgatc cgtacccgtt aaacccatac atctctacga ttatttttga ggtgtctgaa agcataggaa ctctgcaggc ttcattctta cgcaccgtat aagtgtcagt ccaagccgag gaggtagcta acatcatatg cttaat cccg caagctagct cgcgaggtag gggtttccat cctaatagag gtgaccgaca ggtctaaaat atgttccttt atatatagtt gccttggtCt atcactactt gatacgccaa gcgagccagc cgagcagaaa gcaataatac atggccgcct agcatggact aatcacttgt ctggctgctt 120 180 240 300 360 420 480 540 600 660 720 780 840 900 960 WO 03/040322 WO 03/40322PCT/US02/35374 00 gttgtgatcg agc 973 <210> 4 <211> 687 <212> DNA <213> zea mays <220:> <221> promoter <222> <223> MRS4 <220> <221> <222> <220> <221> <222> CAAT.Si gnal (556). .(559) TATA..signal (608) <400> 4 acgatatgaa gttttccttt aacgggctat ctttttcgaa atcttttgac cgacaggtgt tcgactcact tggccaccca agtgggtgca acaatccctg ctataaaaga gaactcgtga ctggtatgtg tttgtggttg agttgcgtta gcagctgatg ctatgtccag aattagtcat atattttcCt ggttcttcca actcatctca ccactgattg gaaacctatc caaaaaggat gatatgcgag caggccaatc aaggaaaatt agcacagctt gttactcatg taattt catt aaggaagata atatctcata cacctcagag tccctagtag caaaagcatg aatccacgac gctcgcacag ggccaagcta ccatcgt catagtttct gctaagtgaa catagcacat actatttcag gatccccact gttaggcata agaatccagt gcaaccaaag acttgcgtga aggcctcact cggtctaaat tcgggcgtga gtagcaatgg aaactgtcgc acgcataaaa acaaagtgtt ggtcgtctgg aatcctccct ttcagttgac agtgtgttcc tccgttgtaa gctcctagct atcccaagag tgtcagccat ttaaaggcga agcgcctcaa ctcaaagata tcaccaatta gagaagatgc cactcacacc <210> WO 03/040322 WO 03140322PCT/US02/35374 <211> 609 <212> DNA ;Z <213> Zea mays <220> <221> misc.feature <222> (589) 00 <223> 22PBS cDNA n-unknown base <220> <221> CDS <222> (589) <400> gcgtccgtaa ctcgaaacct tttcttgtgc tctgtctgtg tgtttccaaa gcaaacgaaa gagctcgagg atg tct tgc agc tgc g ga tca agc tgc aac tgc g ga tca 109 met ser cys Ser Cys Gly Ser Ser CYS Asfl Cys G y ser 1 5 agc cgc aac tgc ggc aag atg tac cct gac ctg gag gag aag agc g~c 157 Ser Arg Asn CYS Gly LYS Met Tyr Pro Asp Leu GlU GlU LYS Ser Gly 20 gg c gct tag gcc agc gcc gcc gcc gtc ctc gpc gtt gcc cct gag 205 G Y Gly Ala Gin Ala ser Ala Ala Ala Val Leu Gi y Val Ala Pro Glu 35 40 acg aag aag gcg gcg cag ttc gag gcg gcg g gc gag tcc gg c gag gcc 253 Thr LYS LYS Ala Ala Gin Phe Glu Al a Al Gy Glu Ser Gly GlU Ala 55 gcc cac ggc tgc agc tgc ggt gac agc tgc aag tgc agc ccg tgc aac 301 Ala His Gly Cys Ser cys G ly Asp Ser Cys Lys Cys Ser Pro Cys Asn 570 tgc nnn tcc tgc tgc gtt gtt tcg ttt gcg gca tgc atg cct gtc act 349 Cys xaa Ser Cys Cys Val Val Ser Phe Ala Ala Cys met Pro Val Thr 85 ttt ttt acg'tac tgt ctg ctt tgt gct tgt ggc gtg tca aga ata aag 397 Phe Phe Thr Tyr Cys Leu Leu Cys Al a Cys Gly Val Ser Arg Ilie Lys 100 105 gat ggagcc atc gtc tgg tct ggctct ggctct ccg CCa g catg ctt 445 As p Gly Ala lie Val TrpSer Gly Ser rG y Ser Pro ProG~y Met Leu 110 115 120 125 ggt gtc ggt tct gtt gtg ctt gt ttg gtg cat gta atc gta tgg cat 493 Gly Val Gly Ser Val Val Leu va Leu Val Hi s Val lie Val Tr His 130 135 14 cgt tac aca cca tgc atc tct gat ctc tgt gcg 7 cta gtg tgt gtg act 541 WO 03/040322 Arg Tyr Thr Pro Cys le Ser ASO Leu Cys Ala Leu Val CS sVal Thr 145 150M atg tcc ctg nnn cga ttg gct caa tat ata caa tac tgt ttt acc aaa met Ser Leu Xaa Arg LeU Ala Gin Ty Ilie Gin Tyr Cys Phe Thr LYS 160 165 170 aaaaaaaaaa aaaaaaaaaa <210> 6 <211> 173 <212> PRT <213> Zea mays <220> <221> misc-feature <222> (589) <223> 22PB8 xaa=unknown amino acid PCTJUS02/35374 589 609 <400> 6 Met Cys Gin Al a Cys cys Ty r Ilie Ser ser Gi y Al a Al a ser cys Cys Val Val 130 se r Met Al a Ph e Gi y Val Leu 100 Se r Leu Cys Ty r Al a GlU ASP Ser CYS Gly Val Asfl Al a LYS Gi y Se r Th r Al a Gi y Th r WO 03/040322 WO 03/40322PCTIUS02/35374 Pro CyS Ilie Ser ASP Leu Cys Ala Leu Val Cys Val Thr Met Ser Leu C1145 150 15 160 ;Z ~Xaa Arg LeU Ala Gin Tyr lie Gin Ty Cys Phe Thr LYS Sn165 170 <210> 7 <211> 766 <212> DNA 00 <213> Zea mays <220> <221> misc-feature <222> (766) <223> 10B21 CONA n unknown base .<220> <221> CDS <222> .(744) <400> 7 tcagttaata. ctaagggcag gcacacctct gcttcgcgct agtgatcaag caagtgcttt ctgtactctg cagca atg gca. gg c aag gcc tcg gtc gcg ctg ttc ctc gcc il1 met Ala Gl1y Lys Ala Ser Val Ala Leu Phe Leu Ala 1 5 gtg aac ctg gtg gtg ttc gcc atg gcc agc gcc tgc ggt ggc aac tgc 159 Val As n Leu Va 1 Va 1Phe Ala Met Ala ser Ala Cys Gl1y G ly Asn Cys 20 ccc acg ccg acc ccg tcc acc ccg tcg acg ccg acc ccg acg ccg gcc 207 Pro Thr Pro Thr Pro ser Thr Pro Ser Thr Pro Thr Pro Thr Pro Ala 35 tcg ttc ggc aag tgc ccc cgc gac gcg ctc aag ctg gg c gtg tgc gcc 255 Ser Phe G y Lys CyS Pro Arg Asp Al a Leu Lys Leu Gy1y Val1 Cys Ala 50 55 aac gtg ctg gga. ctg atc aag gcc aag gt 9 g 9c gtg ccg ccc acg gag 303 Asn Val Leu Gly Leu Ilie Lys Ala Lys Va] Gly Va] Pro Pro Thr Giu 70 cca tgc tgc ccg ctg ctg aag gga ctc gtc gac ctc gag gcc gcc gtg 351 Pro Cys Cys Pro Leu Leu Lys G~y Leu Val Asp LeU Giu Ala Ala Va 85 tgc ctc tgc acc gcc atc aag ggc gag gtc ctc gga atc aag ctc aac 399 cys Leu Cys Thr Ala lie Lys Gly Giu Val Leu Gly Ile Lys Leu Asn 100 105 WO 03/040322 WO 03140322PCTIU S02/353 74 ctg ccc gtC Leu Pro Val 110 ccc acc gg a Pro Thr Gi y 125 tat gtg ttc Tyr ValI Phe tac tta tta Tyr Leu Leu atg ttg atg met Leu met 175 ttc gtc ctt Phe Val Leu 190 ttt tat ttg Phe Tyr Leu 205 att tat tgg le Tyr Trp gac ctc agc ctc atC Ctc Z ASP Leu Ser Leu Ile Leu 115 ttc aaa tgc ctc nnn gct Phe Lys C S Leu Xaa Ala ttt tgg ttg cca ttc gcc 1 Phe Tr~ Leu Pro Phe Al a( agc gag tgc nnn ctc tgc i Ser Glu Cys Xaa Leu Cys 160 165 agc agc ttt cgc ttt tgg Ser Ser Phe Arg Phe Trp N 180 tgc atc gac agt gtc cca cys lie ASP Ser Val Pro 195 tat cca gca atc tgc ttg Tyr Pro Ala Ilie Cys Leu 210 aaaaaaaaaa aaaaaaaaaa aa 447 495 543 591 639 687 735 <210> <211> <212> <213> 8 223 PRT zea mays <220> <221> misc...feature <222> .(766) <223> 10B21 xaa=unknown amino acid <400> 8 Met Ala Gly LyS Ala ser Val Ala Leu Phe Leu Ala Val Asn Leu Val 1 5 10 Val Phe Ala Met Ala ser Ala Cys Gly Gly Asn cys Pro Thr Pro Thr 25 Pro Ser Thr Pro ser Thr Pro Thr Pro Thr Pro Ala Ser Phe Gly Lys 40 Cys Pro Arg ASP Ala LeU Lys Leu Gly Val Cys Ala Asri Val Leu Gly 55 WO 03/040322 WO 03/40322PCTJUS02/35374 Leu Leu Al a Leu LYS Trp 145 GlU Se r le LYS Al a Lys Gly LYS Gly 100 Leu Ile 115 Leu Xaa Pro Phe xaa Leu Arg Phe 180 Ser Val 195 LYS Leu G1U Leu Al a Al a cys 165 Trp Pro Gi y ASP Leu His Arg 135 A rg His Ph e Leu Pro Gi U Iile 105 Gi y His Leu Tyr LeU 185 Gi y Pro Al a 90 Lys LyS Al a Val1 Val 170 cys Leu Th r Al a Leu Thr ASP Val 155 Leu Lys Leu Pro cys Leu Pro 125 Tyr Ty r Met Phe Ph e 205 Cys Cys Val Gi y Phe Leu Met 175 Leu Leu pro Ala le Cys Leu Ile Xaa 210 215 <210> 9 <211> 663 <212> DNA <213> Zea mays <220> <22 1> mi scjfeature <222> (654) <223> 2D14 CDNA n-unknown base Asn Lys Ala Tyr le 220 le Tyr Trp <220> <221> CDS <222> .(654) WO 03/040322 WO 03/40322PCT/US02/35374 <400> 9 cgagca atg gcg tcc aag gca ttc gcg ctg ttc ctg gcc gtg aac ctg Met Ala ser LYS Ala Phe Ala Leu Phe Leu Al a va 1 Asn Leu 1 5 gtg Va1 tcg Sen cgc Arg aag LYS gag Gi u aag ctc Leu nnn Xaa tgc cys ctt Leu cg t Ar aca Th r acg Th r gac ASP gct Al a g c Al a ata Iile tcc S er 160 acg Th r ttt Ph e acg Th r ctc Leu gtg Val gtc Val at c Ilie aac ASfl Ct C Leu 1.30 cat His gta Val ict Se r gta Val aag Lys 210 gta Val ccg Pro aag LYS gac ASP ctc Leu tac Ty r 115 cgt A rg cga Arg cg a Arg aag LYS 195 gcc aac Ala Asn acg ccc Thr Pro ttg g gc Leu G 1y gcg ccg Ala Pro ctg gag LeU GlU 85 100 tgc g c Cys Gly ctc atc Leu Ile tcc gtt Ser Val gag gta Giu Val 165 ttt gta Phe Val 180 gg C tgg G IY Trp gcc tgc acg Ala Cys Thr acg ccg tcg Thr Pro Ser 40 gtg g c Val I gSC Al a ccc gcg gag Pro Ala Glu gcc gcc gCC Ala Ala Ala aac ctc aac Asfl Leu Asfl agg acc gtg Arg Thr val 120 gcc ttg cgc Ala Leu Arg 135 tca gtg acg Ser val Thr 150 ctg cat gca Leu His Ala att tcc cag lie Sen Gin cga tca ctt Arg Ser Leu 200 tcc aac Sen Asn 25 tcg tcc Sen Sen aac gtg Asn va 1 cca tgc Pro Cys tgc ctc CyS Leu ctg ccg Leu Pro 105 ccc acc Pro Thr tgc ctc Cys Leu cat g gt His GI y tgc aac CyS Asn 170 cct ctt Pro Leu 185 cta cgc LeU Arg tcg acc ccc Sen Thr Pro agg tgc ccc Ang cys Pro g~ ctc atc GyLeu lie ccg ctg ctg Pro Leu Leu act gct atc Thr Ala Ilie gat ctc agc ASP Leu Sen 110 ttc aag tgc Phe Lys Cys tcc att cca ser Ile Pro 140 gtt nnn ttg Val xaa Leu tgg ccg tac Tnp Pro Tyr tcc ttg tgt Ser Leu Cys 190 tgc nnn nnn Cys Xaa xaa 205 gtt cca atc val Pro lie ttt cag tgt ttt Phe Gin cys Phe gca tgc aaaaaaaaa Ala Cys 215 <210> <211> 216 <212> PRT <213> zea mays WO 03/040322 WO 03140322PCT1US02/35374 00 <220> <221> <222> <223> mni sc...feature 2D14 xaa-unknown amino acid <400> met Leu Pro Al a Leu As n Leu Pro Leu 145 Hi s Cys Val Al a 61 y rh r Leu s0 V/al Val le Asn Leu 130 His Val Ser Val se r Val Pro Lys Gi Y Asp Leu. Tyr 115 Arg 61 y A rg Arg LYS 195 LYS Ala Phe Ala Asn Ala Thr Pro Thr Leu G ly Val Ala Pro Pro Leu GlU Ala ,gl le Asfl Cys Gly Arg Leu Ile Ala ser Val ser 150 GlU Val Leu 165 Phe Val Ile 180 Gly TrP Arg Phe Ser 25 Se r Asfl Pro Cys Leu 105 Pro cys His Cys Pro 185 Leu Ala Val Asn Cys ser Thr Gly ArgC LeU Gly Leu Cps Pro Leu Cys Thr Ala Val ASP Leu Gly Phe LYS 125 Pro Ser Ilie 140 ser Val xaa 155 Thr Trp Pro Pro ser Leu Arg Cys Xaa 205 Leu Pro Pro Ile Leu Ile Ser 110 Cys Pro Leu Tyr cys 190 Val Thr ASP Ala 61 y 61 y le Al a le Ser 160 Th r Ph e xaa Val Pro 210 l ySPhe GIn Cys Phe Al a Cys 215 WO 03/040322 WO 03140322PCTIUS02/35374 <210> <211> <212> <213> <220> <221L> <223> 11 610 DNA Zea mays mi sc..feature 4H-19 CONA n~un known base CDS (588) <220> <221> <222> <400> 11 actcacaccg aactcgtgaa gcacagcttc catcgt atg atg tcg met met ser 1 agg aag agg Arg LYS Arg aag LYS gtc Val g ct Al a tgt CYS t cg Se r nnn Xaa tg g Trp ctc L eu aag Lys g ca Al a tg C Cys gag Gi u gca Al a atc Ile tct Ser cat HIS 120 agg Arg ccg Pro cat HiS cag Gi n agg Arg att Ile cct Pro 105 ctC Leu 9 c cca Pro g cc Al a gaa Glu cta Leu gat ASP cgt Arg aaa Lys tca Se r gtc Val tgc cys 75 tgt Cys cct Pro gtt Val gaa Gi u tcg Se r cgc Arg ttc Phe 60 nnn xaa gtt Val nnn Xaa gat ASP gaa Gi U gcg Al a cgg Ar-g 45 gcc Al a tgg Trp cgg Arg ttc Phe 125 g aa Gi u gt~ 30 gag Gi u t ttt Ph e agg A rg tca ser 110 cag Gi n nnn gtg Xaa Va I ctt cgg LeU Arg gca caa Ala Gin ctt cca Leu Pro agg g gg Arg Gly tgt ctc CYS Leu cta gaa LeU Glu gt Va] cat His cgc Arg gaa Gi u 65 caa Gin cgt Arg nnn xaa gtc Val cat His gcg Al a tta Leu atc le tac Tyr g cg Ala agt Ser gcg Al a 102 150 198 246 294 342 390 438 486 gaa tgt gtg agc gtg tgt gt~ ttc aag GlU Cys Val Ser Val cys va I Phe Lys tgt cag Cys Gin 14 nnn gcg aac ctt Xaa Ala ASfl Leu WO 03/040322 135 140 145 150 ttg tat ttt gac cgt gtg agt cct gtg tat ttt cag ttg tct p~t gtg Leu ry r Phe ASP A Val Se Pro Va] Tyr Phe Gin Leu Ser Gy Va er 160 165 ttg tgt gtg agt atc tct gaa nnn gaa tgt aat gct ata tgt gtg ccc Leu cys val ser lie Ser GlU Xaa Glu Cys Asn Ala Ilie Cys Vay Pro 170 175 180 gtg caa aaaaaaaaaa aaaaaaaaaa aa Val1 Gin <210> 12 <211> 184 <212> PRT .<213> Zea mays .<220> <221> misc-feature <223> 4H19 xaa=unknown amino acid PCT/US02/35374 534 582 610 <400> 12 met ser Arg ser GlU Ala Ala Ala LYS Arg Gly Leu Arg Arg Gin Leu Pro Leu ser Ile Val 100 Val Cys Val 115 Xaa Pro V'al 130 LyS Ang LeU Val LyS Hi S Val Ala Val Leu ser le Tyr Trp Ser WO 03/040322 WO 03/40322PCTJUS02/35374 Gi n xaa Ala 145 Asfl Leu Ala 150 Leu Tyr Phe Asp Arg Val ser Pro Vial Tyr 155 160 Phe Gin Leu ser Gly Val Leu cys Val Ser le Ser GiU Xaa GlU CYS 165 170 175 Asfl Al~ <210> <211> <212> <213> <220> <221> <22> <223> ale Val Pro Val Gin 13 24 DNA Artificial sequence ml sc...feature .C24) 22P8 cDNA RACE primer-i <400> 13 cacactagcg cacagagatC agag <210> <211> <212> <213> <220> <221> <222> <223> 14 24 DNA Arti fici ai sequence mi s cf eatu re 22P8 cDNA RACE primer-2 <400> 14 gcaccaacac aagcacaaca gaac <210> <211> 24 <212> DNA WO 03/040322 WO 03/40322PCTJUS02/35374 <213> Artificial Sequence <220> <221> <222> <223> ml sc...featu re 22P8 CD NA PACE primer-3 <400> cagggtacat cttgccgcac ttgc <210> 16 <21-1> 24 <212> DNA <213> Artificial sequence <220> <221> <222> <223> mi sc.feature 22P8 CDNA RACE prlmer-4 <400> 16 tgatccgcag ttgcagcttg atcc <210> <211> <212> <213> <220> <221> <222> <223> 17 23 DNA Artificial sequence ml sc..feature .(23) 10B21-CDNA RACE primer-i <400> 17 catgctcgcg gctagcttag agg <210> 18 WO 03/040322 WO 03/40322PCTIUSO2/35374 <211> <212> <213> <220> <221> .e222> <223> 23 DNA Artificial sequence mi sc-featu re (1)..C23) 10821 CDNA RACE primer-2 00 <400> 18 acagtcttgc cgcagtggtt gag <210> 19 <211> <2 12> <213> <220> <221> <22 2> <223> 23 DNA Artificial sequence ml sc-feature 10B21 cDNA RACE primer-3 <400> 19 tgaggctgag gtcgacgggc agg <210> <21-1> <212> <213> <220> <221> <222> <223> 23 DNA Artificial sequence mi sc...feature 10821 cONA RACE primer-4 <400> cgaggtcgac gagtccttc agc WO 03/040322 WO 03/40322PCTIUS02/35374 <210> 21 <211> 24 <212> DNA <213> Artificial Sequence <220> <221> mi sc..f eatu re <222> <223> 2D14 CDNA RACE primer-i <400> 21 ttagcaccgg cgtagaagtg atcg <210> 22 <211> 23 <212> DNA <213> Artificial sequence <220> <221> misc...feature <222> (23) <223> 2D14 cDNA RACE primer-2 <400> 22 gcatggaatg gaagggaggc agc <210> 23 <211> 24 <212> DNA <213> Artificial Sequence <220> <221> <222> <223> ml sc-featu re 4H19 cDNA RACE primer-i WO 03/040322 WO 03/40322PCT/US02/35374 <400> 23 atacaacgca aggttcgctc actg <210> 24 <211> 24 <212> DNA <213> Artificial Sequence <220> <221> mi sc...feature <222> .(24) <223> 4H19 cDNA RACE primer-2 <400> 24 catgaccgct aaggatcagg agac <2 10> <211> <2 12> <213> <220> <221> <222> <223> 23 DNA Artificial sequence ml sc-featu re .(23) 4H19 CONA RACE primer-3 <400> tctttcttgt gcaccgccga agc <210> <211> <212> <213> <220> <221> 26 23 DNA Artificial sequence ml sc-feature WO 03/040322 WO 03/40322PCT/US02/35374 <222> .(23) <223> 4H19 cDNA RACE primer-4 tn <400> 26 tgcactcaca ccgccgatga tgg 23 <210> 27 <211> 27 0C) <212> DNA <213> Artificial Sequence <220> <221> ,iscfeature <222> <223> RACE adaptor primer <400> 27 ccatcctaat acgactcact atagggc 27 <210> 28 <211> <212> DNA <213> Artificial sequence <220> <221> misc...feature <222> <223> 22P8 genomiC-.DNA probe-i <400> 28 tcctcgagct ctttcgtttg ctttggaaac <210> 29 <211> 28 <212> DNA <213> Artificial sequence WO 03/040322 WO 03/40322PCT/US02/35374 <220> <221> miscfeature ;Z<222> (28) <223> 10B21 genomiC-DNA probe-i <400> 29 acaccaccag gttcacggcg aggaacag 28 0C) <210> <211> 28 <212> DNA <213> Artificial sequence <220> <221> misc-feature <222> <223> 10B21 genomlC-DNA probe-2 <400> gaggccttgc ctgccattgc tgcagagt 28 <210> 31 <211> 28 <212> DNA <213> Artificial Sequence <220> <221> misc...feature <222> (28) <223> 2D14 genomi C-DNA probe-i <400> 31 agcagttgga cgtgcaggcg ttggctac 28 <210> 32 <213> 27 <212> DNA WO 03/040322 WO 03/40322PCTIUS02/35374 <213> Artificial Sequence <220> <221> <222> <223> mi sc-.f eatu re C1)..(27) 2D14 genomiC-DNA probe-2 <400> 32 aggttcacgg ccaggaacag cgcgaat <210> 33 <211> 23 <212> <213> DNA Artificial sequence <220> <222.> miscjfeature <222> .(23) <223> 4H19 genomic-DNA probe-i <400> 33 tctttcttgt gcaccgccga agc <210> 34 <211> 23 <212> DNA <213> Artificial sequence 220> <221> misc...feature <222> <223> 4H19 genomic-DNA probe-2 <400> 34 tgcactcaca ccgccgatga tgg <210> WO 03/040322 WO 0/041322PCTIUS02/35374 <211> 22 <212> DNA ;Z <213> Artificial Sequence <220> <221> misc..feature <222> (22) 00 <223> Genome Walker adaptor primer <400> gtaatacgac tcactatagg gc 22 <210> 36 <211> 19 <212> DNA <213> Artificial Sequence <220> <221> misc-feature <222> .(19) <223> 22P8G5P7 primer <400> 36 actatagggc acgcgtggt 19 <210> 37 <211> 37 <212> DNA <213> Artificial Sequence <220> <221> mi s c-fe atu re <222> (37) <223> 5' lambda arm primer <400> 37 ctgcttctca tagagtcttg cagacaaact gcgcaac 37 WO 03/040322 WO 01041322PCT/US02/35374 <210> 38 ;Z <211> 37 <212> DNA <213> Artificial Sequence <220> 00 <221> mi sc..feature <222> .(37) <223> 3' lambda arm primer- <400> 38 tgaacactcg tccgagaata acgagtggat ctgggtc 37 <210> 39 <211> 28 <212> DNA <213> Artificial Sequence <220> <221> misc..feature <222> (28) <223> 22P8Ds1 primer <400> 39 ttaagaacat gacggatgaa gaatcact 28 <210> <211> 24 <212> DNA <213> Artificial Sequence <220> <221> misc..feature <222> <223> 22P8GsP6 primer WO 03/040322 PTU0/57 PCT/US02/35374 <400> tgatccgcag ttgcagcttg atcc 24 <210> 41 <211> .<212> DNA <213> Artificial Sequence 00 <220> <221> misc..feature <222> <223> 22P8DS5 primer <400> 41 acaaaaaagc aggctgaaca tgacggatga <210> 42 <211> <212> DNA <213> Artificial Sequence <220> <221> misc..feature <222> <223> 22P8DS9 primer <400> 42 acaagaaagc tgggtcctcg agctctttcg <210> 43 <211> 29 <212> DNA <213> Artificial Sequence <220> <221> misc-feature WO 03/040322 WO 03140322PCTJIUS02/35374 .(29) (N <223> attBl primer <400> 43 ggggacaagt rtgtacaaaa aagcaggct 29 <210> 44 <211> 29 00 <212> DNA <213> Artificial Sequence <220> <221> misc-feature <222> .(29) <223> attB2 primer <400> 44 ggggaccact ttgtacaaga aagctgggt 29 <210> <211> 27 <212> DNA <213> Artificial Sequence <220> <221> misc..feature <222> .(27) <223> 22PB8D53 primer <400> gcgtagttga agcttacaaa gttgcat 27 <210> 46 <211> <212> DNA <213> Artificial Sequence WO 03/040322 PCT/US02/35374 <220> <221> misc...feature ;Z<222> <223> 22P8DS7 primer <400> 46 acaaaaaagc aggctgtagt tgaagcttac 0C) <210, 47 <211> 26 <212> DNA 0 <213> Artificla Sequence <220> <221> misc-feature <222> (26) <223> 10821DS1 primer <400> 47 gacggcccgg gctggtaaat tgactt 26 <210> 4B <211> 23 <212> DNA <213> Artificial sequence <220> <221> mi s c..featu re <222> .(23) <223> 10o21GsP1 primer <400> 48 catgctcgcg gctagcttag agg 23 <210> 49 <211> 28 <212> DNA WO 03/040322 WO 03/40322PCT/US02/35374 <213> Artificial Sequence ;Z <220> <221> misc-feature <222> .(28) <223> 1OB21DS3 primer 00 <400> 49 CK1tggtaaattg actttgccta gtgttgga 28 <210> <211> 23 <212> DNA <213> Artificial Sequence <220> <221> miscfeature <222> .(23) <223> 10821GSPZ primer <400> acagtcttgc cgcagtggtt gag 23 <210> 51 <211> .<212> DNA <213> Artificial sequence <220> <221> misc-feature <222> <223> 10B21DS5 primer <400> 51 acaaaaaagc aggcttgact ttgcctagtg <210> 52 WO 03/040322 WO 03/40322PCT1US02/35374 <211> <212> DNA ;Z <213> Artificial sequence <220> <221> inisc...feature <222> 00 <223> 10821DS7 primer <400> 52 acaagaaagc tgggttgctg cagagtacag <210> 53 <211> 27 <212> DNA <213> Artificial sequence <220> <221> misc-feature <222> .(27) <223> 2D14DS1 primer <400> 53 atgggtttgc gggtatgggt agtggta 27 <210> 54 <211> 28 <212> DNA <213> Artificial sequence <220> <221> misc-feature <222> <223> 2D1L4GsP5 primer <400> 54 acaccaccag gttcacggcg aggaacag 28 WO 03/040322 WO 03/40322PCT/US02/35374 <210> <211> <212> <213> <220> <221> <222> <223> 29 DNA Artificial sequence mi sc..feature 2D14DS3 primer <400> acaaaaaagc aggctgcggg tatgggtag <210> 56 <211> <212> DNA <213> Artificial Sequence <220> <221> mi sc...feature <222> <223> 2D14D55 primer <400> 56 acaagaaagc tgggttgctc gatcacaaca <210> 57 <211> 23 <212> DNA <213> Artificial sequence <220> <221> <222> <223> mi sc-eature 4H19GSP3 primer WO 03/040322 WO (3/04322PCTIUS02/35374 <400> 57 tctttcttgt gcaccgccga agc 23 <210> 58 <211b <212> DNA <213> Artificial sequence 00 <220> <221> m~sc-~feature <222> r~l<223> 4H19profor primer <400> 58 acccgataac gagttaacga tatgaactgg <210> 59 <211> 23 <212> DNA <213> Artificial sequence <220> <221> misc-feature <222> .(23) <223> 4H19GSP4 primer <400> 59 tgcactcaca ccgccgatga tgg 23 <210> <211b <212> DNA <213> Artificial sequence <220> <221> misc...feature WO 03/040322 WO 03140322PCTIUSO2/35374 <222> <223> 4Hl9proforB1 primer <400> acaaaaaagc aggctaacga tatgaactgg <210> <2 11> <212> <213> <220> <221> <222> <223> 61 DNA Artificial sequence mi s c..f eatu re 4Hl9prorevB2 primer <400> 61 acaagaaagc tgggtcttca cgagttcggt <210> <211> <212> <213> <220> <221> <222> <22 3> 62 DNA Artificial sequence ml sc..featu re rfBclI primer <400> 62 tgcccgtatg atcaacaagt ttgtacaaaa <210> 63 <211> <212> DNA <213> Artificial Sequence WO 03/040322 WO 03/40322PCT11JS02/35374 <220> <221> misc..jeature <222> <223> rfECORV primer <400> 63. ccagaccgat atcaaccact ttgtacaaga <210> 64 <211> <212> <213> <220> <221> <222> <223> DNA Artificial sequence mi sc-featu re MRs2 REV Primer <400> 64 gctgcagagt acagaaagca <210> <211> <212> <213> <220> <221> <222> <223> 24 DNA Artificial sequence ml sc...featu re MRs2-L FWD Primer <400> caccggcttg actttgccta gtgt <210> 66 <211> 24 <212> DNA WO 03/040322 WO 03/40322PCT/US02/35374 <213> Artificial sequence <220> <221> misc..feature <222> .(24) <223> MRS2-M FWD Primer 00 <400> 66 (~KIcacctgcgcg tgttcgtaga gttg 24 <210> 67 <211> 24 C14212> DNA <213> Artificial sequence <220> <221> misc...feature <222> (24) <223> MRS2-S FWD Primer <400> 67 cacctgaact tgtgcacgtc attt 24

类似技术:

---

公开号 | 公开日 | 专利标题

---

US8058420B2|2011-11-15|Promoters for regulation of gene expression in plant roots

---

AU772908B2|2004-05-13|Maize promoters

---

CA2587798A1|2006-05-26|Maize cr1bio gene promoter and its use to direct root-preferred transgene expression in plants

---

AU762798B2|2003-07-03|Root-preferred promoters and their use

---

MX2013009399A|2013-09-26|Root-preferred promoter and methods of use.

---

WO2002038588A2|2002-05-16|Putrescine-n-methyltransferase promoter

---

WO2001094394A2|2001-12-13|Plant ubiquitin promoter sequences and methods of use

---

US20130025000A1|2013-01-24|Promoter for regulation of gene expression in plant roots

---

AU2007202802B2|2011-04-21|Promoters for regulation of gene expression in plant roots

---

US8927702B2|2015-01-06|Solanum bulbocastanum polyubiquitin Bul409 promoter and uses thereof

---

AU2011203548A1|2011-09-01|Promoters for regulation of gene expression in plant roots

---

AU2011203549A1|2011-08-18|Promoters for regulation of gene expression in plant roots

---

AU2008221550B2|2015-01-22|Solanum bulbocastanum polyubiquitin Bul409 promoter and uses thereof

---

US8921656B2|2014-12-30|Solanum bulbocastanum polyubiquitin Bul427 promoter and uses thereof

---

CA2639943A1|2010-03-18|Solanum bulbocastanum polyubiquitin promoter and uses thereof

同族专利:

---

公开号 | 公开日

---

AU2007202802B2|2011-04-21|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

US5837848A|1990-03-16|1998-11-17|Zeneca Limited|Root-specific promoter|

---

法律状态:
2011-08-18| FGA| Letters patent sealed or granted (standard patent)|

---

2014-05-29| MK14| Patent ceased section 143(a) (annual fees not paid) or expired|

优先权:

---

申请号 | 申请日 | 专利标题

---

US60/337,026||2001-11-07||

---

AU2002354015A|AU2002354015B2|2001-11-07|2002-11-04|Promoters for regulation of gene expression in plant roots|

---

AU2007202802A|AU2007202802B2|2001-11-07|2007-06-15|Promoters for regulation of gene expression in plant roots|AU2007202802A| AU2007202802B2|2001-11-07|2007-06-15|Promoters for regulation of gene expression in plant roots|